Podcasts about Haverford College

In this episode of the Braun Performance & Rehab Podcast, Dan is joined by Sam Cohen to discuss the mental performance side of baseball and lessons from sport applied to life.Sam Cohen is a rising senior at Haverford College, where he is pursuing a degree in Computer Science and serving as a captain of the college's baseball team. Originally from Ellicott City, Maryland, Sam was not heavily recruited out of high school. However, through a strong process-oriented approach, he has developed into a successful collegiate pitcher. Sam credits baseball with shaping both his mental and physical resilience. He reflects on how the challenges and triumphs of his athletic journey have prepared him for success beyond the field. For more on Sam be sure to follow @sam_c_18*SEASON 6 of the Braun Performance & Rehab Podcast is brought to you by Isophit. For more on Isophit, please check out isophit.com and @isophit -BE SURE to use coupon code BraunPR25% to save 25% on your Isophit order!**Season 6 of the Braun Performance & Rehab Podcast is also brought to you by Firefly Recovery, the official recovery provider for Braun Performance & Rehab. For more on Firefly, please check out https://www.recoveryfirefly.com/ or email jake@recoveryfirefly.com***This episode is also powered by Dr. Ray Gorman, founder of Engage Movement. Learn how to boost your income without relying on sessions. Get a free training on the blended practice model by following @raygormandpt on Instagram. DM my name “Dan” to @raygormandpt on Instagram and receive your free breakdown on the model.Episode Affiliates:MoboBoard: BRAWNBODY10 saves 10% at checkout!AliRx: DBraunRx = 20% off at checkout! https://alirx.health/MedBridge: https://www.medbridgeeducation.com/brawn-body-training or Coupon Code "BRAWN" for 40% off your annual subscription!CTM Band: https://ctm.band/collections/ctm-band coupon code "BRAWN10" = 10% off!Ice shaker affiliate link: https://www.iceshaker.com?sca_ref=1520881.zOJLysQzKeMake sure you SHARE this episode with a friend who could benefit from the information we shared!Check out everything Dan is up to by clicking here: https://linktr.ee/braun_prLiked this episode? Leave a 5-star review on your favorite podcast platform

The Federal Reserve holds interest rates steady. Chair Jerome Powell says there still is too much uncertainty in how Trump Administration policies, especially tariffs, will affect the economy, inflation and job growth; Treasury Secretary Scott Bessent testifies before a House committee about his meeting this weekend with Chinese officials on tariffs and trade; more Trump Administration officials go before House Appropriations Subcommittee about their agencies' budgets, including Energy Secretary Chris Wright, FEMA Acting Administrator Cameron Hamilton and FBI Director Kash Patel; Attorney General Pam Bondi announces the arrest of over 200 alleged child sex predators; Rep. Elise Stefanik (R-NY) questions the President of Haverford College at a hearing on college antisemitism; Vice President JD Vance says Russia is "asking for too much" in peace negotiations with Ukraine; former President Joe Biden talks about war in Ukraine in a BBC Radio interview, his first since leaving office; black smoke comes out the chimney on the Sistine Chapel at The Vatican, meaning no pope elected on the first ballot of the Conclave. Learn more about your ad choices. Visit megaphone.fm/adchoices

1 - Bucks County Sheriff Fred Harran joins us mere hours after launching his podcast and after a very public Town Hall. What will the podcast be about? Why are people online saying that Fred's plan to restore law and order to Bucks County is similar to that of the Nazis, when in fact, Fred is Jewish! Why is the local media covering him so harshly? What can be done to combat drug importing in the area? 110 - Some audio of Elise Stefanik grilling Haverford College's President. 120 - Continuing with colleges and rhetoric. Should Mo Khan be kicked out of Temple for his bottle service sign? 150 - What an impatient seagull. Your calls.

12 - Will we get the Epstein files? Why tout that you will release them, only to walk that back? 1215 - Side - all time photograph 1220 - Dom recaps last night's Politics and Pints and gives kudos to our listeners for such great questions and conversation. Dom made another Top 100 list! 1235 - Getting Dan's answer and more on the Top 100 list. Your calls. 1250 - Returning to the Sauce vs. Gravy argument which transpires to another one about pizza. 1 - Bucks County Sheriff Fred Harran joins us mere hours after launching his podcast and after a very public Town Hall. What will the podcast be about? Why are people online saying that Fred's plan to restore law and order to Bucks County is similar to that of the Nazis, when in fact, Fred is Jewish! Why is the local media covering him so harshly? What can be done to combat drug importing in the area? 110 - Some audio of Elise Stefanik grilling Haverford College's President. 120 - Continuing with colleges and rhetoric. Should Mo Khan be kicked out of Temple for his bottle service sign? 150 - What an impatient seagull. Your calls. 2 - Former US Deputy National Security Advisor. Served four US Presidents; Geopolitics Expert KT McFarland joins us. Which President was most exciting to work for? What is the tool that Trump is using to gain economic dominance back? Why would Trump tease a big announcement right before heading to the middle east? How is Trump going to get the upper hand away from Putin again? 215 - Dom's Money Melody! 225 -How fraudulent are these Catholic Universities almost encouraging anti-Semitism on their campus? 250 - The Lightning Round!

DePaul University President Robert Manuel will take part in a hearing this week called “Beyond the Ivy League: Stopping the Spread of Antisemitism on American Campuses.” Haverford College and California Polytechnic State University presidents are also called to testify. Reset digs into what's behind the hearing with WBEZ higher education reporter Lisa Kurian Philip. For a full archive of Reset interviews, head over to wbez.org/reset.

1 - NJ Assemblywoman Dawn Fantasia joins us today. How is the “S2 Democrat Formula” hurting New Jersey schools and taxpayers alike? Why won't Democrats cross the aisle in order to get some bipartisan support on a new school funding bill instead of using an antiquated system? How is this playing into NJ's lack of affordability? Why do most gubernatorial candidates on the left not understand budgeting? Why is school choice so important to Dawn? Is Mikie Sherrill a “moderate”? 120 - BREAKING NEWS: There's a fight going down tonight! Also, Dom's dentist played the accordion for him while he was in the chair? Returning to overpaid teachers in the area. Your calls. 135 - Former Senator and current Newsmax contributor Rick Santorum joins us live from Rome! Is it gravy or sauce? How important is it for these social media companies to empower parents rather than the government to regulate them? What is the Vatican looking like? Is this Conclave feeling like an election? Why will this one be so different? Is there a divide politically? 150 - Haverford College's President is under fire for defending anti-Semitism as they had the same protests that the Ivy League schools had, but without the protections. Your calls.

12 - Which local school district are paying non-teachers the most with your taxpayer money? 1205 - A discussion on the Pulitzer winning photo spread yesterday capturing the attempted assassination of Trump in Butler, PA. Returning back to the school districts and their salaries. 1210 - Listen as Morning Joe tries to justify Obama's deportations but disparaging Trump's at the same time. 1215 - Side - all time medical professional 1220 - How will Trump reign in China? Your calls. 1235 - Political commentator and senior contributor at American Greatness Julie Kelly joins the show today. What can she tell us about the Ashli Babbitt lawsuit being settled? How big of a task has it been for the Trump administration to turn the FBI around? Will we ever get full transparency on the Jeffrey Epstein case? How do we live in a society where federal judges are superseding the President's authority? How is it clearing out the “deep-state” within the Executive Branch? What is Julie working on now? 1250 - Man it must be good living being a teacher in the area. Previewing tonight. 1 - NJ Assemblywoman Dawn Fantasia joins us today. How is the “S2 Democrat Formula” hurting New Jersey schools and taxpayers alike? Why won't Democrats cross the aisle in order to get some bipartisan support on a new school funding bill instead of using an antiquated system? How is this playing into NJ's lack of affordability? Why do most gubernatorial candidates on the left not understand budgeting? Why is school choice so important to Dawn? Is Mikie Sherrill a “moderate”? 120 - BREAKING NEWS: There's a fight going down tonight! Also, Dom's dentist played the accordion for him while he was in the chair? Returning to overpaid teachers in the area. Your calls. 135 - Former Senator and current Newsmax contributor Rick Santorum joins us live from Rome! Is it gravy or sauce? How important is it for these social media companies to empower parents rather than the government to regulate them? What is the Vatican looking like? Is this Conclave feeling like an election? Why will this one be so different? Is there a divide politically? 150 - Haverford College's President is under fire for defending anti-Semitism as they had the same protests that the Ivy League schools had, but without the protections. Your calls. 2 - The NFL is starting to take over football ratings, but where does that leave NCAAF and High School Football when their is overlap between games? Ted Cruz is taking them on to keep the NFL at bay. 205 - What is the Trump secret formula to getting the media to talk about him? How did he come up with this Alcatraz idea? Was a movie on TV? Sean Duffy puts his foot down 210 - Your calls. 215 - Dom's Money Melody! 225 -RFK Jr. is looking to undo all of Dr. Fauci's damage, but why is the media reporting it differently? 235 - Congressman Jeff Van Drew joins us today. What is it like being a dentist and keeping your patients entertained? Who is his all time medical professional? With budget being the big talking point lately, what can he assure us about Medicaid and what Congress is looking to cut from the outrageous spending? How are they curtailing waste, fraud, and abuse within our government? The left and the media may say Republicans are hurting kids by slashing things within the budget and deporting migrants, but the citizens know what we're doing. 250 - The Lightning Round!

Megan Williams joins Let's Talk Memoir for a conversation about being a new mother while training at the police academy, looking for validation, resisting the urge to punish ourselves, pushing back against the voice of patriarchal culture, writing to our past self, going too far and not going far enough, the loneliness of motherhood, setting boundaries in memoir, testing ourselves, what motherhood feels like now, moving elegantly through time in memoir, surrounding yourself with talented writers, frontloading a manuscript, and her memoir One Bad Mother: A Mother's Search for Meaning in the Police Academy. Also in this episode: -thinking as a form of writing -writing community -writing conferences     Books mentioned in this episode: Crossing the River by Carol Smith  Starry Field by Margaret Juhae Lee Bastard Out of Carolina by Dorothy Alliosn You Could Make This Place Beautiful by Maggie Smith A Well-Trained Wife by Tia Levings   Megan Williams is the author of One Bad Mother: A Mother's Search for Meaning in the Police Academy. After graduating from Haverford College, Megan received her Ph.D. in English from Temple University and taught at Lafayette College and Santa Clara University. She has moved across the country—never landing in the middle—three times in twenty years. She now lives in Bellingham with her husband, who runs Blue Dog Bakery and keeps their teenage twins, rescued cat, horse, and mastiff full of treats. Connect with Megan Williams: Website: www.meganwilliamsauthor.com Facebook: https://www.facebook.com/profile.php?id=1347114175 Instagram: https://www.instagram.com/ottoisking/ Tiktok: @one.bad.mother LinkedIn: https://www.linkedin.com/in/megan-williams-6585844a/ Get the book: https://bookshop.org/p/books/one-bad-mother-a-woman-s-search-for-meaning-in-motherhood-and-the-philadelphia-police-academy-megan-williams/20964845?ean=9781960573858   – Ronit's writing has appeared in The Atlantic, The Rumpus, The New York Times, Poets & Writers, The Iowa Review, Hippocampus, The Washington Post, Writer's Digest, American Literary Review, and elsewhere. Her memoir WHEN SHE COMES BACK about the loss of her mother to the guru Bhagwan Shree Rajneesh and their eventual reconciliation was named Finalist in the 2021 Housatonic Awards Awards, the 2021 Indie Excellence Awards, and was a 2021 Book Riot Best True Crime Book. Her short story collection HOME IS A MADE-UP PLACE won Hidden River Arts' 2020 Eludia Award and the 2023 Page Turner Awards for Short Stories.  She earned an MFA in Nonfiction Writing at Pacific University, is Creative Nonfiction Editor at The Citron Review, and teaches memoir through the University of Washington's Online Continuum Program and also independently. She launched Let's Talk Memoir in 2022, lives in Seattle with her family of people and dogs, and is at work on her next book. More about Ronit: https://ronitplank.com Subscribe to Ronit's Substack: https://substack.com/@ronitplank Follow Ronit: https://www.instagram.com/ronitplank/ https://www.facebook.com/RonitPlank https://bsky.app/profile/ronitplank.bsky.social   Background photo credit: Photo by Patrick Tomasso on Unsplash Headshot photo credit: Sarah Anne Photography Theme music: Isaac Joel, Dead Moll's Fingers

Send us a textOn today's episode we have Coach Bobbi Morgan. Coach Morgan has experience as an assistant at Widener University. She has experience as a head coach at Academy of Notre Dame, Haverford High School, Cabrini College, and Haverford College—where she remains the winningest coach in program history (notching 3 Centennial Conference championships, four NCAA Division III Tournament appearances, two NCAA regional finals, and is a three-time Centennial Conference Coach of the Year). Currently, she is the head coach at Ursinus College.Beyond the collegiate level, Coach Morgan has worked with USA Basketball as both a court coach and assistant coach for National Junior Women's Teams. In 2023, she helped guide the U16 national team to a gold medal at the FIBA Americas Championship. She has also been named an assistant coach for the 2024 U17 national team, which will compete for a FIBA World Championship.On this episode we discuss:Tips to prepare for college level defenseWhat coach's are looking for when watching highlight and game filmWhy being proactive in the recruiting process is vitalThe skills that translate to the college levelHow to navigate multiple offersQuestions to ask current student athletes when on a visitAnd much more!Ursinus Women's basketball InstagramCoach Morgan X AccountUrsinus Women's basketball recruiting questionnaireWhen you work with me you can expect a 360-degree player development plan designed specifically for young female basketball players.If this sounds interesting, let's have a conversation - send me an email today - hoopsthroughlife@gmail.comCheck out Hoops Through Life on: Hoops Through Life WebsiteXInstagramFacebookIf you have any questions for me or our future guests email hoopsthroughlife@gmail.comThe views and opinions shared by coaches and other professionals on this podcast are solely their own and do not necessarily reflect those of Hoops Through Life. Hoops Through Life is an independent entity, not affiliated with any school or coach, and is not responsible for the opinions expressed by these individuals.

Betty Medsger is the author of the forthcoming book, THE BURGLARY, as well as: Winds of Change, Framed, and Women at Work. She lives in New York.In late 1970, a mild-mannered Haverford College physics professor privately asked a few people this question: “What do you think of burglarizing an FBI office?” In remarkable detail and with astonishing depth of research, Betty Medsger reveals the never-before-told full story of the history-changing break-in at the Media, Pennsylvania, FBI offices. Through their exploits, a group of unlikely activists exposed the shocking truth that J. Edgar Hoover was operating a shadow Bureau engaged in illegal surveillance and harassment of the American people.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-opperman-report--1198501/support.

Lately, I've been thinking a lot about the passage of time, about priorities, about health, about our larger purpose. I've been thinking, too, about intentionality. What is it that I want to do with my career? Am I doing the work that feeds me and my community? Or am I pursuing projects not because they are meaningful to me, but because this is what I am expected to do at this juncture of my career? And what of my health?Am I putting up guardrails to make sure that I'm not sacrificing my health for the academy and not letting corrosive institutional pressures get to me? I'm sure that these are questions that many of us grapple with. And who better to think through these questions than my dear friend, Dr. Gina Velasco. Dr. Velasco is an Associate Professor and Director of Gender and Sexuality studies at Haverford College. Her book, Queering the Global Filipina Body, was published by the University of Illinois Press in 2020.Gina and I have known each other for 10 years, and I've always appreciated our hangouts where we both just chill and talk about work and life. I've also really admired how Gina's relationship with work has evolved over the past decade as she battled major health challenges and life changes that led her to understand, as she puts it, the impermanence of being healthy.Related LinksGina K. Velasco, Ph.D.Queering the Global Filipina Body: Contested Nationalisms in the Filipina/o Diaspora

About two years ago, we released a podcast with Dr. Thomas Wadden of the University of Pennsylvania describing work on a new generation of medications to treat diabetes and obesity. They were really taking the field by storm. Since then, much more is known since many additional studies have been published and so many people have been using the drugs. So many, in fact, the market value of the Danish company, Novo Nordisk, one of the two major companies selling the drugs, has gone up. It is now greater than the entire budget of the country of Denmark. This single company is responsible for about half of Denmark's economic expansion this year. So, a lot of people are now taking the drugs and this is a great time for an update on the drugs. And we're fortunate to have two of the world's leading experts join us: Dr. Wadden, Professor of Psychology and Psychiatry at the University of Pennsylvania School of Medicine and the inaugural Albert J. Stunkard Professor of Psychiatry at Penn. Joining us as well as Dr. Robert Kushner, a physician and professor of medicine at Northwestern University and a pioneer in testing treatments for obesity. Interview Summary Tom, you and I were colleagues at Penn decades ago. And I got frustrated the treatments for obesity didn't work very well. People tended to regain the weight. And I turned my attention to prevention and policy. But you hung in there and I admired you for that patience and persistence. And Bob, the same for you. You worked on this tenacious problem for many years. But for both of you, your patience has been rewarded with what seems to me to be a seismic shift in the way obesity and diabetes can be treated. Tom, I'll begin with you. Is this as big of a deal as it seems to me? Well, I think it is as big of a deal as it seems to you. These medications have had a huge impact on improving the treatment of type 2 diabetes, but particularly the management of obesity. With older medications, patients lost about 7 percent of their starting weight. If you weighed 200 pounds, you'd lose about 15 pounds. That was also true of our best diet and exercise programs. You would lose about 7 percent on those programs with rigorous effort. But with the new medications, patients are now losing about 15 to 20 percent of their starting body weight at approximately one year. And that's a 30-to-40-pound loss for a person who started at 200 pounds. And with these larger weight losses, we get larger improvements in health in terms of complications of obesity. So, to quote a good friend of mine, Bob Kushner, these medications have been a real game changer. Thanks for putting that in perspective. I mean, we're talking about not just little incremental changes in what treatments can produce, which is what we've seen for years. But just orders of magnitude of change, which is really nice to see. So, Bob what are these medications that we're talking about? What are the names of the drugs and how do they work? Well, Kelly, this transformation of obesity really came about by finding the target that is really highly effective for obesity. It's called the gut brain axis. And when it comes to the gut it's starting off with a naturally occurring gut hormone called GLP 1. I think everyone in the country's heard of GLP 1. It's released after we eat, and it helps the pancreas produce insulin, slows the stomach release of food, and reduces appetite. And that's where the obesity story comes in. So pharmaceutical companies have taken this hormone and synthesized it, something similar to GLP 1. It mimics the action of GLP 1. So, you could actually take it and give it back and have it injected so it augments or highlights this hormonal effect. Now, that same process of mimicking a hormone is used for another gut hormone called GIP that also reduces appetite. These two hormones are the backbone of the currently available medication. There's two on the market. One is called Semaglutide. That's a GLP 1 analog. Trade name is Wegovy. Now, it's also marketed for diabetes. Tom talked about how it is used for diabetes and increases insulin. That trade name is Ozempic. That's also familiar with everyone around the country. The other one that combined GLP 1 and GIP, these two gut hormones, so it's a dual agonist, the trade name for obesity is called Zep Bound, and the same compound for diabetes is called Mounjaro. These are terms that are becoming familiar, I think, to everyone in the country. Tom mentioned some about the, how much weight people lose on these drugs, but what sort of medical changes occur? Just to reiterate what Tom said, I'll say it in another way. For Semaglutide one third of individuals are losing 20 percent of their body weight in these trials. For Tirzepatide, it even outpaces that. And I got a third of individuals losing a quarter of their body weight. These are unheard of weight losses. And with these weight losses and these independent effects from weight, what we're seeing in the trials and in the clinic is that blood pressure goes down, blood sugar goes down, blood fats like triglyceride go down, inflammation in the body goes down, because we marked that with CRP, as well as improvement in quality of life, which we'll probably get to. But really interesting stuff is coming out over the past year or two or so, that it is improving the function of people living with congestive heart failure, a particular form called a preserved ejection fraction. We're seeing improvements in sleep apnea. Think of all the people who are on these CPAP machines every night. We're seeing significant improvements in the symptoms of sleep apnea and the apneic events. And lastly, a SELECT trial came out, that's what it was called, came out last year. Which for the very first time, Kelly, found improvements in cardiovascular disease, like having a heart attack, stroke, or dying of cardiovascular disease in people living with obesity and already have cardiovascular disease. That's called secondary prevention. That, Tom, is the game changer. Bob, I'd like to go back to Tom in a minute but let me ask you one clarifying question about what you just said. That's a remarkable array of biological medical benefits from these drugs. Just incredible. And the question is, are they all attributable to the weight loss or is there something else going on? Like if somebody lost equal amounts of weight by some other means, would these same changes be occurring? Those studies are still going on. It's very good. We're thinking it's a dual effect. It's the profound amount of weight loss, as Tom said. Fifteen to 21 to even 25 percent of average body weight. That is driving a lot of the benefits. But there also appear to be additional effects or weight independent effects that are working outside of that weight. We're seeing improvements in kidney function, improvement in heart disease, blood clotting, inflammation. And those are likely due to the gut hormone effect independent of the weight itself. That still needs to be sorted out. That's called a mitigation analysis where we try to separate out the effects of these drugs. And that work is still underway. Tom, one of the most vexing problems, over the decades that people have been working on treatments for obesity, has been long term results. And I'm curious about how long have people been followed on these drugs now? What are the results? And what was the picture before then? How do what we see now compared to what you saw before? The study that Bob just mentioned, the SELECT trial followed people for four years on Semaglutide. And patients achieve their maximal weight loss at about one year and they lost 10 percent of their weight. And when they were followed up at four years still on treatment, they still maintained a 10 percent weight loss. That 10 percent is smaller than in most of the trials, where it was a 15 percent loss. But Dr. Tim Garvey showed that his patients in a smaller trial lost about 15 percent at one year and while still on medication kept off the full 15 percent. I think part of the reason the weight loss in SELECT were smaller is because the study enrolled a lot of men. Men are losing less weight on this medication than women. But to your question about how these results compare to the results of earlier treatment, well with behavioral treatment, diet, and exercise back in the 70s beyond, people lost this 7 or 8 percent of weight. And then most people on average regain their weight over one to three years. And the same was true of medication. People often stopped these earlier medications after 6 to 12 months, in part because they're frustrated the losses weren't larger. Some people were also worried about the side effects. But the long and short is once you stop taking the medication, people would tend to regain their weight. And some of this weight regain may be attributable to people returning to their prior eating and activity habits. But one of the things we've learned over the past 20 years is that part of the weight regain seems to be attributable to changes in the body's metabolism. And you know that when you lose weight, you're resting metabolic rate, which is the number of calories your body burns at rest to maintain basic bodily functions. Your resting metabolic rate decreases by 10 to 15 percent. But also, your energy expenditure, the calories you burn during exercise decreases. And that may decrease by as much as 20 to 30 percent. So, people are left having to really watch their calories very carefully because of their lower calorie requirements in order to keep off their lost body weight. I think one thing these new drugs may do is to attenuate the drop both in resting metabolic rate and energy expenditure during physical activity. But the long and short of it is that if you stay on these new medications long term, you'll keep off your body weight. And you'll probably keep it off primarily because of improvements in your appetite, so you have less hunger. And as a result, you're eating less food. I'd like to come back to that in a minute. But let me ask a question. If a person loses weight, and then their body starts putting biological pressure on them to regain, how come? You know, it's disadvantageous for their survival and their health to have the excess weight. Why would the body do that? Well, our bodies evolved in an environment of food scarcity, and our physiology evolved to protect us against starvation. First, by allowing us to store body fat, a source of energy when food is not available. And second, the body's capacity to lower its metabolism, or the rate at which calories are burned to maintain these basic functions like body temperature and heart rate. That provided protection against food scarcity. But Kelly, you have described better than anybody else that these ancient genes that regulate energy expenditure and metabolism are now a terrible mismatch for an environment in which food is plentiful, high in calories, and available 24 by 7. The body evolved to protect us from starvation, but not from eating past our calorie needs. And so, it's this mismatch between our evolution and our appetite and our body regulation in the current, what you have called toxic food environment, when you can eat just all the time. I guess you could think about humans evolving over thousands of years and biology adapting to circumstances where food was uncertain and unpredictable. But this modern environment has happened really pretty rapidly and maybe evolution just hasn't had a chance to catch up. We're still existing with those ancient genes that are disadvantageous in this kind of environment. Bob back to the drugs. What are the side effects of the drugs? Kelly, they're primarily gastrointestinal. These are symptoms like nausea, diarrhea, constipation, heartburn, and vomiting. Not great, but they're generally considered mild to moderate, and temporary. And they primarily occur early during the first four to five months when the medications are slowly dose escalated. And we've learned, most importantly, how to mitigate or reduce those side effects to help people stay on the drug. Examples would be your prescriber would slow the dose escalation. So. if you're having some nausea at a particular dose, we wait another month or two. The other, very importantly, is we have found that diet significantly impacts these side effects. When we counsel patients on these medications, along with that comes recommendations for dietary changes, such as reducing fatty food and greasy food. Reducing the amount of food you're consuming. Planning your meals in advance. Keeping well hydrated. And very importantly, do not go out for a celebration or go out to meals on the day that you inject or at least the first two days. Because you're not going to tolerate the drug very well. We use that therapeutically. So, if you want to get control on the weekends, you may want to take your injection on a Friday. However, if weekends are your time out with friends and you want to socialize, don't take it on a Friday. Same thing comes with a personal trainer, by the way. If you're going to have a personal trainer on a Monday where he's going to overwork you, don't take the injection the day before. You'll likely be nauseated, you're not eating, you're not hydrating. So actually, there's a lot that goes into not only when to take the dose and how to take the dose, but how to take it to the best ability to tolerate it. Two questions based on what you said. One is you talked about these are possible side effects, but how common are they? I mean, how many people suffer from these? Well, the trials show about 25 to 45 percent or so of individuals actually say they have these symptoms. And again, we ask them mild, moderate, severe. Most of them are mild to moderate. Some of them linger. However, they really do peak during the dose escalation. So, working with your prescriber during that period of time closely, keeping contact with them on how to reduce those side effects and how you're doing out of medication is extremely important. And the second thing I wanted to ask related to that is I've heard that there's a rare but serious potential side effect around the issue of stomach paralysis. Can you tell us something about that? I mentioned earlier, Kelly, that these medications slow gastric emptying. That's pretty much in everybody. In some individuals who may be predisposed to this, they develop something called ileus, and that's the medical term for gastric paralysis. And that can happen in individuals, let's say who have a scleroderma, who have longstanding diabetes or other gastrointestinal problems where the stomach really stopped peristalsis. In other words, it's moving. That's typically presented by vomiting and really unable to move the food along. We really haven't seen much of that. We looked at the safety data in a SELECT trial that Tom mentioned, which was 17,000 individuals, about 8,000 or so in each group. We really did not see a significant increase in the ileus or what you're talking about in that patient population. Okay, thanks. Tom had alluded to this before, Bob, but I wanted to ask you. How do you think about these medicines? If somebody takes them, and then they stop using the medicines and they gain the weight back. Is that a sign that the medicine works or doesn't work? And is this the kind of a chronic use drug like you might take for blood pressure or cholesterol? That's a great way of setting up for that. And I like to frame it thinking of it as a chronic progressive disease, just like diabetes or hypertension. We know that when you have those conditions, asthma could be another one or inflammatory bowel disease, where you really take a medication long term to keep the disease or condition under control. And we are currently thinking of obesity as a chronic disease with dysfunctional appetite and fat that is deposited in other organs, causing medical problems and so on. If you think of it as a chronic disease, you would naturally start thinking of it, like others, that medication is used long term. However, obesity appeared to be different. And working with patients, they still have this sense 'that's my fault, I know I can do it, I don't want to be on medication for the rest of my life for this.' So, we have our work cut out for us. One thing I can say from the trials, and Tom knows this because he was involved in them. If we suddenly stop the medication, that's how these trials were definitely done, either blindly or not blindly, you suddenly stop the medication, most, if not all of the participants in these trials start to regain weight. However, in a clinical practice, that is not how we work. We don't stop medication suddenly with patients. We go slowly. We down dose the medication. We may change to another medication. We may use intermittent therapy. So that is work that's currently under development. We don't know exactly how to counsel patients regarding long term use of the medications. I think we need to double down on lifestyle modification and counseling that I'm sure Tom is going to get into. This is really work ahead of us, how to maintain medication, who needs to be on it long term, and how do we actually manage patients. Tom, you're the leading expert in the world on lifestyle change in the context of obesity management. I mean, thinking about what people do with their diet, their physical activity, what kind of thinking they have related to the weight loss. And you talked about that just a moment ago. Why can't one just count on the drugs to do their magic and not have to worry about these things? Well, first, I think you can count on the drugs to do a large part of the magic. And you may be surprised to hear me say that. But with our former behavioral treatments of diet and exercise, we spent a lot of time trying to help people identify how many calories they were consuming. And they did that by recording their food intake either in paper and pencil or with an app. And the whole focus of treatment was trying to help people achieve a 500 calorie a day deficit. That took a lot of work. These medications, just by virtue of turning down your appetite and turning down your responsiveness to the food environment, take away the need for a lot of that work, which is a real blessing. But the question that comes up is, okay, people are eating less food. But what are they eating? Do these medications help you eat a healthier diet with more fruits and vegetables, with lean protein? Do you migrate from a high fat, high sugar diet to a Mediterranean diet, or to a DASH like diet? And the answer is, we don't know. But obviously you would like people to migrate to a diet that's going to be healthier for you from a cardiovascular standpoint, from a cancer risk reduction standpoint. One of the principal things that people need to do on these medications is to make sure they get plenty of protein. And so, guidance is that you should have about 1 gram of dietary protein for every kilogram of body weight. If you're somebody who weighs 100 kilograms, you should get 100 grams of protein. And what you're doing is giving people a lot of dietary protein to prevent the loss of bodily protein during rapid weight loss. You did a [00:20:00] lot of research with me back in the 80s on very low-calorie diets, and that was the underpinning of treatment. Give people a lot of dietary protein, prevent the loss of bodily protein. The other side of the equation is just physical activity, and it's a very good question about whether these medications and the weight loss they induce will help people be more physically active. I think that they will. Nonetheless for most people, you need to plan an activity schedule where you adopt new activities, whether it's walking more or going to the gym. And one thing that could be particularly helpful is strength training, because strength training could mitigate some of the loss of muscle mass, which is likely to occur with these medications. So, there's still plenty to learn about what is the optimal lifestyle program, but I think people, if they want to be at optimal health will increase their physical activity and eat a diet of fruits and vegetables, leaner protein, and less ultra processed foods. Well, isn't it true that eating a healthy diet and being physically active have benefits beyond their impact on your ability to lose the weight? You're getting kind of this wonderful double benefit, aren't you? I believe that is true. I think you're going to find that there are independent benefits of being physical activity upon your cardiovascular health. There are independent benefits of the food that you're eating in terms of reducing the risk of heart attack and of cancer, which has become such a hot topic. So, yes how you exercise and what you eat makes a difference, even if you're losing weight. Well, plus there's probably the triple one, if you will, from the psychological benefit of doing those things, that you do those things, you feel virtuous, that helps you adhere better as you go forward, and these things all come together in a nice picture when they're working. Tom, let's talk more about the psychology of these things. You being a psychologist, you've spent a lot of time doing research on this topic. And of course, you've got a lot of clinical experience with people. So as people are losing weight and using these drugs, what do they experience? And I'm thinking particularly about a study you published recently, and Bob was a coauthor on that study that addressed mental health outcomes. What do people experience and what did you find in that study? I think the first things people experience is improvements in their physical function. That you do find as you've lost weight that you've got less pain in your knees, you've got more energy, it's easier to get up the stairs, it's easier to play with the children or the grandchildren. That goes a long way toward making people feel better in terms of their self-efficacy, their agency in the life. Big, big improvement there. And then, unquestionably, people when they're losing a lot of weight tend to feel better about their appearance in some cases. They're happy that they can buy what they consider to be more fashionable clothes. They get compliments from friends. So, all of those things are positive. I'm not sure that weight loss is going to change your personality per se, or change your temperament, but it is going to give you these physical benefits and some psychological benefits with it. We were happy to find in the study you mentioned that was conducted with Bob that when people are taking these medications, they don't appear to be at an increased risk of developing symptoms of depression or symptoms of suicidal ideation. There were some initial reports of concern about that, but the analysis of the randomized trials that we conducted on Semaglutide show that there is no greater likelihood of developing depression or sadness or suicidal ideation on the medication versus the placebo. And then the FDA and the European Medicines Agency have done a full review of all post marketing reports. So, reports coming from doctors and the experience with their patients. And in looking at those data the FDA and the European Medicines Agency have said, we don't find a causal link between these medications and suicidal ideation. With that said, it's still important that if you're somebody who's taking these medications and you start them, and all of a sudden you do feel depressed, or all of a sudden you do have thoughts like, maybe I'd be better off if I weren't alive any longer, you need to talk to your primary care doctor immediately. Because it is always possible somebody's having an idiosyncratic reaction to these medications. It's just as possible the person would have that reaction without being on a medication. You know, that, that can happen. People with overweight and obesity are at higher risk of depression and anxiety disorders. So, it's always going to be hard to tease apart what are the effects of a new medication versus what are just the effects of weight, excess weight, on your mood and wellbeing. You know, you made me think of something as you were just speaking. Some people may experience negative effects during weight loss, but overall, the effects are highly positive and people are feeling good about themselves. They're able to do more things. They fit in better clothes. They're getting good feedback from their environment and people they know. And then, of course, there's all the medical benefit that makes people feel better, both psychologically and physically. Yet there's still such a strong tendency for people to regain weight after they've lost. And it just reinforces the fact that, the point that you made earlier, that there are biological processes at work that govern weight and tendency to regain. And there really is no shame in taking the drug. I mean, if you have high blood pressure, there's no shame in taking the drug. Or high cholesterol or anything else, because there's a biological process going on that puts you at risk. The same thing occurs here, so I hope the de-shaming, obesity in the first place, and diabetes, of course, and then the use of these medications in particular might help more people get the benefits that is available for them. I recommend that people think about their weight as a biologically regulated event. Very much like your body temperature is a biologically regulated event, as is your blood pressure and your heart rate. And I will ask people to realize that there are genetic contributors to your body weight. just as there are to your height. If somebody says, I just feel so bad about being overweight I'll just talk with them about their family history of weight and see that it runs in the family. Then I'll talk to them about their height. Do you feel bad about being six feet tall, to a male? No, that's fine. Well, that that's not based upon your willpower. That's based upon your genes, which you received. And so, your weight, it's similarly based. And if we can use medications to help control weight, cholesterol, blood pressure, blood sugar, let's do that. It's just we live in a time where we're fortunate to have the ability to add medications to help people control health complications including weight. Bob, there are several of the drugs available. How does one think about picking between them? Well, you know, in an ideal medical encounter, the prescriber is going to take into consideration all the factors of prescribing a medication, like any other medication, diabetes, hypertension, you name the condition. Those are things like contraindication to use. What other medical problems does the patient have that may benefit the patient. Patient preferences, of course and side effects, safety, allergies, and then we have cost. And I'll tell you, Kelly, because of our current environment, it's this last factor, cost, that's the most dominant factor when it comes to prescribing medication. I'll have a patient walk in my room, I'll look at the electronic medical record, body mass index, medical problems. I already know in my head what is going to be the most effective medication. That's what we're talking about today. Unfortunately, I then look at the patient insurance, which is also on the electronic medical record, and I see something like Medicaid or Medicare. I already know that it's not going to be covered. It is really quite unfortunate but ideally all these factors go into consideration. Patients often come in and say, I've heard about Ozempic am I a candidate for it, when can I get it? And unfortunately, it's not that simple, of course. And those are types of decisions the prescriber goes through in order to come to a decision, called shared decision making with the patient. Bob, when I asked you the initial question about these drugs, you were mentioning the trade name drugs like Mounjaro and Ozempic and those are made by basically two big pharmaceutical companies, Novo Nordisk and Eli Lilly. But there are compounded versions of these that have hit the scene. Can you explain what that means and what are your thoughts about the use of those medications? So compounding is actually pretty commonly done. It's been approved by the FDA for quite some time. I think most people are familiar with the idea of compounding pharmacies when you have a child that must take a tablet in a liquid form. The pharmacy may compound it to adapt to the child. Or you have an allergy to an ingredient so the pharmacy will compound that same active ingredient so you can take it safely. It's been approved for long periods of time. Anytime a drug is deemed in shortage by the FDA, but in high need by the public, compounding of that trade drug is allowed. And that's exactly what happened with both Semaglutide and Tirzepatide. And of course, that led to this compounding frenzy across the country with telehealth partnering up with different compounding pharmacies. It's basically making this active ingredient. They get a recipe elsewhere, they don't get it from the company, they get this recipe and then they make the drug or compound it themselves, and then they can sell it at a lower cost. I think it's been helpful for people to get the drug at a lower cost. However, buyer beware, because not all compounded pharmacies are the same. The FDA does not closely regulate these compounded pharmacies regarding quality assurance, best practice, and so forth. You have to know where that drug is coming from. Kelly, it's worth noting that just last week, ZepBound and Mounjaro came off the shortage list. You no longer can compound that and I just read in the New York Times today or yesterday that the industry that supports compounding pharmacies is suing the FDA to allow them to continue to compound it. I'm not sure where that's going to go. I mean, Eli Lilly has made this drug. However, Wegovy still is in shortage and that one is still allowed to be compounded. Let's talk a little bit more about costs because this is such a big determinant of whether people use the drugs or not. Bob, you mentioned the high cost, but Tom, how much do the drugs cost and is there any way of predicting what Bob just mentioned with the FDA? If the compounded versions can't be used because there's no longer a shortage, will that decrease pressure on the companies to keep the main drug less expensive. I mean, how do you think that'll all work out? But I guess my main question is how much these things cost and what's covered by insurance? Well first how much do the drugs cost? They cost too much. Semaglutide, known in retail as Wegovy, is $1,300 a month if you do not have insurance that covers it. I believe that Tirzepatide, known as ZepBound, is about $1,000 a month if you don't have insurance that covers that. Both these drugs sometimes have coupons that bring the price down. But still, if you're going to be looking at out of pocket costs of $600 or $700 or $800 a month. Very few people can afford that. The people who most need these medications are people often who are coming from lower incomes. So, in terms of just the future of having these medications be affordable to people, I would hope we're going to see that insurance companies are going to cover them more frequently. I'm really waiting to see if Medicare is going to set the example and say, yes, we will cover these medications for anybody with a BMI of 40 or a BMI of 35 with comorbidities. At this point, Medicare says, we will only pay for this drug if you have a history of heart attack and stroke, because we know the drug is going to improve your life expectancy. But if you don't have that history, you don't qualify. I hope we'll see that. Medicaid actually does cover these medications in some states. It's a state-by-state variation. Short of that, I think we're going to have to have studies showing that people are on these medications for a long time, I mean, three to five years probably will be the window, that they do have a reduction in the expenses for other health expenditures. And as a result, insurers will see, yes, it makes sense to treat excess weight because I can save on the cost of type 2 diabetes or sleep apnea and the like. Some early studies I think that you brought to my attention say the drugs are not cost neutral in the short-term basis of one to two years. I think you're going to have to look longer term. Then I think that there should be competition in the marketplace. As more drugs come online, the drug prices should come down because more will be available. There'll be greater production. Semaglutide, the first drug was $1,300. Zepbound, the second drug Tirzepatide, $1,000. Maybe the third drug will be $800. Maybe the fourth will be $500. And they'll put pressure on each other. But I don't know that to be a fact. That's just my hope. Neither of you as an economist or, nor do you work with the companies that we're talking about. But you mentioned that the high cost puts them out of reach for almost everybody. Why does it make sense for the companies to charge so much then? I mean, wouldn't it make sense to cut the price in half or by two thirds? And then so many more people would use them that the company would up ahead in the long run. Explain that to me. That's what you would think, for sure. And I think that what's happened right now is that is a shortage of these drugs. They cannot produce enough of them. Part of that is the manufacturing of the injector pens that are used to dispense the drug to yourself. I know that Novo Nordisk is building more factories to address this. I assume that Lilly will do the same thing. I hope that over time we will have a larger supply that will allow more people to get on the medication and I hope that the price would come down. Of course, in the U. S. we pay the highest drug prices in the world. Fortunately, given some of the legislation passed, Medicare will be able to negotiate the prices of some of these drugs now. And I think they will negotiate on these drugs, and that would bring prices down across the board. Boy, you know, the companies have to make some pretty interesting decisions, don't they? Because you've alluded to the fact that there are new drugs coming down the road. I'm assuming some of those might be developed and made by companies other than the two that we're talking about. So, so investing in a whole new plant to make more of these things when you've got these competitor drugs coming down the road are some interesting business issues. And that's not really the topic of what we're going to talk about, but it leads to my final question that I wanted to ask both of you. What do you think the future will bring? And what do you see in terms of the pipeline? What will people be doing a year from now or 2 or 5? And, you know, it's hard to have a crystal ball with this, but you two have been, you know, really pioneers and experts on this for many years. You better than anybody probably can answer this question. Bob, let me start with you. What do you think the future will bring? Well, Kelly, I previously mentioned that we finally have this new therapeutic target called the gut brain axis that we didn't know about. And that has really ushered in a whole new range of potential medications. And we're really only at the beginning of this transformation. So not only do we have this GLP 1 and GIP, we have other gut hormones that are also effective not only for weight loss, but other beneficial effects in the body, which will become household names, probably called amylin and glucagon that joins GLP 1. And we not only have these monotherapies like GLP 1 alone, we are now getting triagonists. So, we've got GIP, GLP 1, and glucagon together, which is even amplifying the effect even further. We are also developing oral forms of GLP 1 that in the future you could presumably take a tablet once a day, which will also help bring the cost down significantly and make it more available for individuals. We also have a new generation of medications being developed which is muscle sparing. Tom talked about the importance of being strong and physical function. And with the loss of lean body mass, which occurs with any time you lose weight, you can also lose muscle mass. There's drugs that are also going in that direction. But lastly, let me mention, Kelly, I spend a lot of my time in education. I think the exciting breakthroughs will not be meaningful to the patient unless the professional, the provider and the patient are able to have a nonjudgmental informative discussion during the encounter without stigma, without bias. Talk about the continuum of care available for you, someone living with obesity, and get the medications to the patient. Without that, medications over really sit on the shelf. And we have a lot of more work to do in that area. You know, among the many reasons I admire the both of you is that you've, you've paid a lot of attention to that issue that you just mentioned. You know, what it's like to live with obesity and what people are experiencing and how the stigma and the discrimination can just have devastating consequences. The fact that you're sensitive to those issues and that you're pushing to de-stigmatize these conditions among the general public, but also health care professionals, is really going to be a valuable advance. Thank you for that sensitivity. Tom, what do you think? If you appear into the crystal ball? What does it look like? I would have to agree with Bob that we're going to have so many different medications that we will be able to combine together that we're going to see that it's more than possible to achieve weight losses of 25 to 30 percent of initial body weight. Which is just astonishing to think that pharmaceuticals will be able to achieve what you achieve now with bariatric surgery. I think that it's just, just an extraordinary development. Just so pleased to be able to participate in the development of these drugs at this stage of career. I still see a concern, though, about the stigmatization of weight loss medications. I think we're going to need an enormous dose of medical education to help doctors realize that obesity is a disease. It's a different disease than some of the illnesses that you treat because, yes, it is so influenced by the environment. And if we could change the environment, as you've argued so eloquently, we could control a lot of the cases of overweight and obesity. But we've been unable to control the environment. Now we're taking a course that we have medications to control it. And so, let's use those medications just as we use medications to treat diabetes. We could control diabetes if the food environment was better. A lot of medical education to get doctors on board to say, yes, this is a disease that deserves to be treated with medication they will share that with their patients. They will reassure their patients that the drugs are safe. And that they're going to be safe long term for you to take. And then I hope that society as a whole will pick up that message that, yes, obesity and overweight are diseases that deserve to be treated the same way we treat other chronic illnesses. That's a tall order, but I think we're moving in that direction. BIOS Robert Kushner is Professor of Medicine and Medical Education at Northwestern University Feinberg School of Medicine, and Director of the Center for Lifestyle Medicine in Chicago, IL, USA. After finishing a residency in Internal Medicine at Northwestern University, he went on to complete a post-graduate fellowship in Clinical Nutrition and earned a Master's degree in Clinical Nutrition and Nutritional Biology from the University of Chicago. Dr. Kushner is past-President of The Obesity Society (TOS), the American Society for Parenteral and Enteral Nutrition (ASPEN), the American Board of Physician Nutrition Specialists (ABPNS), past-Chair of the American Board of Obesity Medicine (ABOM), and Co-Editor of Current Obesity Reports. He was awarded the ‘2016 Clinician-of-the-Year Award' by The Obesity Society and John X. Thomas Best Teachers of Feinberg Award at Northwestern University Feinberg School of Medicine in 2017. Dr. Kushner has authored over 250 original articles, reviews, books and book chapters covering medical nutrition, medical nutrition education, and obesity, and is an internationally recognized expert on the care of patients who are overweight or obese. He is author/editor of multiple books including Dr. Kushner's Personality Type Diet (St. Martin's Griffin Press, 2003; iuniverse, 2008), Fitness Unleashed (Three Rivers Press, 2006), Counseling Overweight Adults: The Lifestyle Patterns Approach and Tool Kit (Academy of Nutrition and Dietetics, 2009) and editor of the American Medical Association's (AMA) Assessment and Management of Adult Obesity: A Primer for Physicians (2003). Current books include Practical Manual of Clinical Obesity (Wiley-Blackwell, 2013), Treatment of the Obese Patient, 2nd Edition (Springer, 2014), Nutrition and Bariatric Surgery (CRC Press, 2015), Lifestyle Medicine: A Manual for Clinical Practice (Springer, 2016), and Obesity Medicine, Medical Clinics of North America (Elsevier, 2018). He is author of the upcoming book, Six Factors to Fit: Weight Loss that Works for You! (Academy of Nutrition and Dietetics, December, 2019). Thomas A. Wadden is a clinical psychologist and educator who is known for his research on the treatment of obesity by methods that include lifestyle modification, pharmacotherapy, and bariatric surgery. He is the Albert J. Stunkard Professor of Psychology in Psychiatry at the Perelman School of Medicine at the University of Pennsylvania and former director of the university's Center for Weight and Eating Disorders. He also is visiting professor of psychology at Haverford College. Wadden has published more than 550 peer-reviewed scientific papers and abstracts, as well as 7 edited books. Over the course of his career, he has served on expert panels for the National Institutes of Health, the Federal Trade Commission, the Department of Veterans Affairs, and the U.S. House of Representatives. His research has been recognized by awards from several organizations including the Association for the Advancement of Behavior Therapy and The Obesity Society. Wadden is a fellow of the Academy of Behavioral Medicine Research, the College of Physicians of Philadelphia, the Obesity Society, and Society of Behavioral Medicine. In 2015, the Obesity Society created the Thomas A. Wadden Award for Distinguished Mentorship, recognizing his education of scientists and practitioners in the field of obesity.

In this podcast, Andy Lee Roth discusses the annual publication of Project Censored State of the Free Press, which takes the pulse of the media and shares the 25 most essential but underreported stories of the past year. Editors Mickey Huff, Shealeigh Voit, and Andy Lee Roth look back on a year in which significant news stories lost out to coverage of celebrities and non-events. They highlight 25 of the most underreported stories of 2024.   Andy Lee Roth is the associate director of Project Censored, a nonprofit media watchdog organization. He coordinates the Campus Affiliates Program, a network of students and faculty at colleges and universities across North America who research and identify the top "censored" news stories. He earned a PhD in Sociology from the University of California–Los Angeles and a BA in Sociology and Anthropology from Haverford College.     Order the book: https://www.penguinrandomhouse.com/books/760692/project-censoreds-state-of-the-free-press-2025-by-mickey-huff/ Greg's Blog: http://zzs-blg.blogspot.com/ Pat's Substack: https://patcummings.substack.com/about   AndyLeeRoth#AndyRoth#MickeyHuff#ShealeighVoit#StateoftheFree Press2025#ProjectCensord#FreePress2025##AI#algorithms#SocialMedia#MediaBias#Censorship#FirstAmendment#Journalism#Newsworthiness#AlgorithmicLiteracy#ShadowBanning#HorseRaceReporting#AlanMacleod#KevinGosztola#Gatekeepingmodel#Censorshipbyproxy#qualitativedataanalysis#PatCummings#PatrickCummings#GregGodels#ZZBlog#ComingFromLeftField#ComingFromLeftFieldPodcast#zzblog#mltoday

Bridget Moix is the fifth General Secretary of the Friends Committee on National Legislation (FCNL). She also leads two other Quaker organizations, affiliated with FCNL: Friends Place on Capitol Hill and FCNL Education Fund. She is a passionate Quaker peace advocate, activist, and mother. Bridget rejoined FCNL as General Secretary in January 2022. Early in her career, she had interned at FCNL. She actually started her career at FCNL 1996. She brings with her 25 years of work on international peace and conflict issues, with a focus on US foreign policy. Prior to joining FCNL, she served as US Executive Director of Peace Direct (2015-2021). As a teacher, she has taught courses in peacebuilding, conflict resolution, and Quaker studies at several institutions, including Haverford College, Columbia University, George Washington University, American University, and Eastern Mennonite University. Bridget holds a Ph.D. from George Mason University's Jimmy and Rosalynn Carter School for Conflict Analysis and Resolution. She focused her dissertation on understanding the motivations of local peacebuilders and how the international community can better support them. She is author of “Choosing Peace: Agency and Action in the Midst of War” (Rowman & Littlefield, 2019), and a contributing author to “Building Peace in America” (Rowman & Littlefield, 2020) as well as “The Handbook of Conflict Resolution: Theory and Practice” (Josey-Bass; 2006; 2014).

In his 1979 Whole Earth Catalog, Stewart Brand wrote, “We are as gods, so we might as well get good at it.” Based on his time on the Mississippi River, however, Boyce Upholt concludes “that we do not make very good gods.” In the final pages of The Great River: The Making and Unmaking of the Mississippi, Upholt reflects, “The river is an unappeasable god, and to react to it with fear and awe is not wrong. . . . Perhaps what people learn after thousands of years of living along one of the world's greatest rivers is that change is inevitable, that chaos will come. That the only way to survive is to take care–of yourself and of everyone else, human and beyond.”Boyce Upholt is a “nature critic” whose writing probes the relationship between humans and the rest of the natural world, especially in the U.S. South. Boyce grew up in the Connecticut suburbs and holds a bachelor's degree from Haverford College and an MFA from the Program for Writers at Warren Wilson College. His work has been published in the Atlantic, National Geographic, the Oxford American, and Virginia Quarterly Review, among other publications, and was awarded the 2019 James Beard Award for investigative journalism. His stories have been noted in the Best American Science & Nature and Best American Nonrequired Reading series. Boyce lives in New Orleans.Book photo courtesy of Boyce Upholt.

In this episode of the ChinaPower Podcast, Mr. Jon Czin joins us to discuss domestic dynamics and leadership decisionmaking within the People's Republic of China's (PRC). Mr. Czin discusses what is currently missing in the conversation within the United States on Chinese politics and the fact that many analysts failed to predict the scope and concentration of power that President Xi Jinping would be able to garner. He describes his humanistic approach to studying decisionmaking by Chinese leadership, attempting to look at issues through the eyes of Xi Jinping and the context within China in which Xi makes these decisions. Mr. Czin discusses his impression of Xi Jinping and both how and why he is vastly different from his predecessors, using Xi's unique past as a primary reason for his style of leadership. He speaks to Xi's focus on domestic and party issues, such as widespread corruption, and discusses what he sees as the limited connection that exists currently between China's internal dynamics and its foreign policy. Mr. Czin shares his assessment that China has arrived as a defining force in the geopolitical environment and in 10 to 20 years China will continue to have the capacity and the will to be a formidable rival to the United States. Finally, he discusses what he sees as China's view of the United State's internal dynamics and the upcoming presidential election. Mr. Jonathan A. Czin is the Michael H. Armacost Chair in Foreign Policy Studies at Brookings Institution and a fellow in the John L. Thornton China Center. He is a former member of the Senior Analytic Service at CIA, where he was one of the intelligence community's top China experts. Jon led the intelligence community's analysis of Chinese politics and policymaking, playing a central role in assessing and briefing senior policymakers on President Xi Jinping, his rise to power, and decisionmaking on an array of key issues and crises. From 2021 till 2023, he was director for China at the National Security Council, where he advised on, staffed, and coordinated White House and inter-agency diplomacy with the People's Republic of China, including all of President Biden's interactions with President Xi, and played a leading role in addressing a wide range of global China issues. He also served as advisor for Asia-Pacific security affairs in the Office of the Secretary of Defense, and overseas at a CIA field station in Southeast Asia. He holds a master's in international relations from Yale University, graduated magna cum laude from Haverford College, and studied at Oxford University. He is proficient in Mandarin Chinese.

*Audio recording of a panel orgnized by friend of the show Frances Hasso. Video edition coming soon!* Convened by Dr. Frances S. Hasso, Professor of Gender, Sexuality and Feminist Studies, History, and Sociology, as part of The Palestine Seminar at Duke University https://gendersexualityfeminist.duke.edu/literary-gaza-hybrid Speakers “My Age is Thirty-five Years Old and Five Wars" Basman Aldirawi  Basman Aldirawi (also Basman Derawi) is a Palestinian and Gazan, a refugee from Bi'r al-Saba`, and currently in Egypt due to the aggression on Gaza. He works as a physiotherapist at the Gaza Ministry of Health and since 2018 has been a member of the Gaza Poets Society, the first spoken word community in Gaza. He has contributed dozens of stories and poems to many online platforms and publications, including We Are Not Numbers (2019), Light in Gaza: Writings Born of Fire (2022), and the We Are Not Numbers online platform that gives a voice to the victims of Israeli aggression in Gaza/Palestine. "The Demon of Gaza" Esmat Elhalaby Esmat Elhalaby is an Assistant Professor of transnational history at the University of Toronto. He works principally on the intellectual history of West and South Asia, particularly colonial and anti-colonial thought. “The 5 Stages of Grief, According to a Palestinian” Samah Serour Fadil Samah Serour Fadil is an Afro-Palestinian writer, editor and translator. Her work has been featured at the Yale University Art Gallery, Fresno State University and The Cantor Fitzgerald Gallery at Haverford College, among others.  “Tent in the Sky” Alaa Na`eem `Ali Al-Qatrawi:   Alaa Na`eem `Ali al-Qatrawi completed her PhD in 2022 in Arabic Literature and Criticism at the Islamic University in Gaza, focused on the poetry of Adonis. Her MA thesis at the Islamic University, which examined Ahmed Bakhit's poetry, won the Award for Best MA thesis in the Humanities in 2015. Dr. Al-Qatrawi is an accomplished poet and short story and operetta writer, winning among others the Abdulaziz Al-Babtain Award for the best poetry collection in the category of young poets in 2022, first in the Union of Palestinian Writers Competition in 2015, first in the Ministry of Culture's poetry competition among all Palestinian universities in 2013, first in short stories in the Arab world in the international competition organized by Chinese Books and Dar Fadaat Publishing House in Amman (2019), and first in the Letter to Jerusalem competition (2010). She works as an Arabic Language teacher in UNRWA schools at the elementary and secondary levels. She has previously worked as a linguist and screenwriter for UNRWA children's programming. Dr. Alaa's Instagram and Facebook pages. Sponsor Department of Gender, Sexuality, and Feminist Studies, Duke University Co-Sponsor(s) Asian & Middle Eastern Studies Program (AMES); History Department; Middle East Studies Center (DUMESC); Asian American & Diaspora Studies Program

**Milestone 300! We dedicate this, the 300th weekly episode, to our loyal listeners, and we wish to recognize the valiant work of our underpaid podcast crew – correction: our unpaid podcast crew – who have put in thousands of hours editing audio, correcting transcripts, writing show notes, creating artwork, and posting promos on social media. To have the next 300 episodes delivered to your inbox as soon as they're released, subscribe at realprogressives.substack.com Project Censored has been a valuable resource for Macro N Cheese. This week, sociologist Andy Lee Roth talks with Steve about information gatekeeping by big tech through their use of AI algorithms to stifle diverse voices. The discussion highlights historical and current instances of media censorship and looks at the monopolization of news distribution by corporate giants like Google, Facebook, and Twitter. In an economic system that is fully privatized, trustworthy journalism is another casualty. News, which should be treated as a public good, is anything but. Andy Lee Roth is associate director of Project Censored, a nonprofit that promotes independent journalism and critical media literacy education. He is the coauthor of The Media and Me (2022), the Project's guide to critical media literacy for young people, and “Beyond Fact-Checking” (2024), a teaching guide about news frames and their power to shape our understanding of the world. Roth holds a PhD in sociology from the University of California, Los Angeles, and a BA in sociology and anthropology from Haverford College. His research and writing have been published in a variety of outlets, including Index on Censorship, In These Times, YES! Magazine, The Progressive, Truthout, Media Culture & Society, and the International Journal of Press/Politics. During 2024-2025 his current work on Algorithmic Literacy for Journalists is supported by a fellowship from the Reynolds Journalism Institute. projectcensored.org @ProjectCensored on Twitter

Jessica Droste Yagan is the CEO of Impact Engine, and she has built a career based on her values and a clear demonstration of authenticity. We talk about how she did it, why it's important, and how it benefits you and everyone around you.Jessica shares her journey from McDonald's to Impact Engine, where she manages venture capital and private equity strategies focused on sustainable and impactful investments. She recounts her moment of realization while studying urban economics, where she realized that capitalism can be used to create sustainable jobs and wealth in high poverty areas.You can align your personal values with business success and contributing to a more transparent and impactful society – and Jessica shares with us how! About the Guest:Jessica Droste Yagan is the CEO of Impact Engine, an investment firm with a mission to bring more capital to a market where financial returns are linked to positive social and environmental impacts. Impact Engine manages venture capital and private equity strategies that invest in transformative for-profit, positive-impact funds and businesses.Prior to Impact Engine, Jessica led the creation of McDonald's Corporation's global and U.S. sustainable sourcing strategies. At McDonald's, she enabled the integration of ethical, environmental, and economic sustainability across all food and packaging sourcing. Jessica also worked in urban economic development through the City Advisory Practice at the Initiative for a Competitive Inner City. Jessica has co-authored two Harvard University case studies on public-private partnerships and currently serves as a board member for the Metropolitan Planning Council, the Rustandy Center for Social Sector Innovation at Chicago Booth, and Fixer. Crain's Chicago Business named her to its list of 40-Under-40 in 2013 and she served as a 2014Leadership Greater Chicago Fellow. Jessica holds a BA in Public Policy from Haverford College, an MBA from the Stanford University Graduate School of Business, and an MPA from the Harvard University Kennedy School of Government. She lives in Chicago with her husband and three children. https://www.theimpactengine.com/ About the Host:Amy L. Riley is an internationally renowned speaker, author and consultant. She has over 2 decades of experience developing leaders at all levels. Her clients include Cisco Systems, Deloitte and Barclays.As a trusted leadership coach and consultant, Amy has worked with hundreds of leaders one-on-one, and thousands more as part of a group, to fully step into their leadership, create amazing teams and achieve extraordinary results. Amy's most popular keynote speeches are:The Courage of a Leader: The Power of a Leadership LegacyThe Courage of a Leader: Create a Competitive Advantage with Sustainable, Results-Producing Cross-System CollaborationThe Courage of a Leader: Accelerate Trust with Your Team, Customers and CommunityThe Courage of a Leader: How to Build a Happy and Successful Hybrid Team Her new book is a #1 international best-seller and is entitled, The Courage of a Leader: How to Inspire, Engage and Get Extraordinary Results. www.courageofaleader.comhttps://www.linkedin.com/in/amyshoopriley/ Resources mentioned in the podcastThe Inspire Your Team to Greatness assessment (the courage assessment).How can you inspire our team to be more proactive, take ownership and get more done?You demonstrate and empower The Courage of a Leader. In my nearly 3 decades of work with leaders, I've...

Mark Shaiken lives with his wife Loren and their dog Emily in Denver Colorado. He schooled at Haverford College and Washburn University, and practiced commercial bankruptcy law for almost 4 decades before moving on to writing, board service, and his photography and music. You can learn more about Mark Shaiken and his work at markshaikenauthor.com TOPICS OF CONVERSATION About "It's What Makes Me... Me" and the inspiration behind the book Intimacy/vulnerability when writing about personal topics On aging and more... Writing fiction vs. non-fiction Handling feeback How different creative outlets influence writing What's next for Mark Shaiken? IT'S WHAT MAKES ME... ME It's What Makes Me... Me is an extraordinarily candid journey through what it means to be human. Amazon's bestselling and award-winning author Mark Shaiken unlocks his most personal thoughts, observations, and introspections through the highs and lows, youth and aging, and beauty and messiness of life. Laugh, reflect, and take in all the ins and outs that have uniquely combined to make Mark... Mark. CONNECT WITH MARK SHAIKEN! Website: htttp://markshaikenauthor.com  LinkedIn:  https://www.linkedin.com/company/mark-shaiken-author YouTube: https://youtu.be/Dp4M6P7Kvvg?si=lzDB3BXd1Q1P5tmy  Facebook: https://www.facebook.com/people/Mark-Shaiken-Author/100070831924501/ Twitter: https://twitter.com/MarkShaiken 

August 8, 2024 This episode features an interview with Shevanthi Daniel-Rabkin, Senior Program Director of DAWI, and Theodora Rodine, Executive Assistant and Project Coordinator for the U.S. Federation of Worker Cooperatives. They will discuss the upcoming 2024 Worker Co-op Conference (WCC24), set to take place in Chicago, IL from September 12-14. Celebrating its 20th year, the Worker Co-op Conference has consistently united a vibrant community of budding, seasoned, and prospective entrepreneurs. This year's event will highlight the increasing trend of worker ownership in the U.S., alongside a revitalized effort for union organizing, steering the nation towards improved working conditions, better wages, and greater employee influence in the workplace. Shevanthi (Shev) Daniel-Rabkin is Senior Program Director of DAWI. Shevanthi provides strategic support on program implementation and growth for DAWI's conversion work with city municipalities, technical assistance providers, legacy business owners and consulting services. Shevanthi comes to DAWI after successfully launching and implementing worker cooperative management certificate programs, as well as a city focused cooperative education and incubation program at the Center for Inclusive Entrepreneurship. Shev is passionate about the intersection of sustainable business and economic development with particular emphasis on direct impacts for people of color. Shevanthi co-founded the O'Dell Education Center, a nonviolence direct action and leadership academy in Washington State, owned and operated by the Institute for Community Leadership. She currently serves on the board of Refugee Women's Alliance (ReWA) and served as Executive Board President at the Center for Women in Democracy, strengthening women's capacity and leadership in the public and private sectors. Shevanthi has an MBA in Sustainable Business from Pinchot University and BA in History and Anthropology from University of Washington. Theodora Rodine is the Executive Assistant and Project Coordinator for the U.S. Federation of Worker Cooperatives. She works on coordinating technical support for co-ops, helps plan conferences and events, and supports the Executive Director. Theodora grew up in San José, California and has lived in South Philadelphia ever since graduating from Haverford College in 2019. She is a member of the Philadelphia Public Banking Coalition and the Philadelphia Area Cooperative Alliance (PACA) Policy and Advocacy Committee, and she attends Central Philadelphia Monthly Meeting. Theodora is an extrovert who loves talking, theatre, and the color yellow. She would like to learn more about policy, decolonization, dogs, and local hiking trails. About the Worker Co-op Conference The Worker Co-op Conference is the only national event where worker-owners from across the United States gather to learn and build power together. The conference is co-hosted by Democracy at Work Institute (DAWI) and the U.S. Federation of Worker Cooperatives as the organizations celebrate their 10th and 20th anniversaries respectively. The conference cultivates a network of interconnected and interdependent worker owners, business developers, policymakers, funders, and labor organizers, all driven toward a common goal of improving the lives of workers and their families. WCC24 will foster relationships and strategies within the worker co-op community and knit us closer to other labor movements.

Betty Medsger is the author of the forthcoming book, THE BURGLARY, as well as: Winds of Change, Framed, and Women at Work. She lives in New York.In late 1970, a mild-mannered Haverford College physics professor privately asked a few people this question: “What do you think of burglarizing an FBI office?” In remarkable detail and with astonishing depth of research, Betty Medsger reveals the never-before-told full story of the history-changing break-in at the Media, Pennsylvania, FBI offices. Through their exploits, a group of unlikely activists exposed the shocking truth that J. Edgar Hoover was operating a shadow Bureau engaged in illegal surveillance and harassment of the American people.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-opperman-report--1198501/support.

Bianca van Heydoorn spoke at this year's FGC Gathering, held this year at Haverford College, just outside of Philadelphia, which made it much easier to have Bianca here for Spirit In Action.

How do you know when to stay the course or press the panic button during market volatility?In this special episode, Ryan Detrick, Chief Market Strategist at Carson Group & Sonu Varghese, VP, Global Macro Strategist at Carson Group, chat with Barry Gilbert, CFA®, Ph.D. Vice President, Asset Allocation Strategist at Carson Group, and Grant Engelbart CFA®, CAIA®, Vice President, Investment Strategist at Carson Group, for a discussion of this period of heightened market turmoil. The team dives into the recent volatility triggered by the Bank of Japan's actions, the impact of weak job data on the Fed's interest rate decisions, and the ripple effects on both global and domestic markets. They discuss: The Bank of Japan's unexpected moves and their impact on global marketsAnalysis of recent job data and what it means for future Fed rate cutsHow current earnings reports reflect broader market conditionsDiversification strategies to manage riskAnd more!Resources:Any questions about the show? Send it to us! We'd love to hear from you! factsvsfeelings@carsongroup.com Connect with Barry Gilbert: LinkedIn: Barry GilbertConnect with Grant Engelbart: LinkedIn: Grant EngelbartConnect with Ryan Detrick: LinkedIn: Ryan DetrickX: Ryan DetrickConnect with Sonu Varghese: LinkedIn: Sonu VargheseX: Sonu VargheseAbout Barry Gilbert:Barry Gilbert is a Vice President, Asset Allocation Strategist. As the VP, Asset Allocation Strategist, Barry Gilbert combines a background in thought leadership with a pragmatic and disciplined approach to portfolio management.Barry holds a PhD in philosophy from Boston University, an MA from the Pennsylvania State University, and a BA from Haverford College. A former educator, he taught finance and economics in the MSF and MBA programs at Northeastern University's D'Amore-McKim School of Business. Prior to his career in asset management, Barry taught philosophy, the history of ideas, and writing and rhetoric at Harvard University, Trinity College and Boston University, and has served as a visiting research fellow at the Institute for Human Sciences in Vienna, an international think tank in politics and economics.About Grant Engelbart:Grant Engelbart serves as Vice President, Investment Strategist for Carson Group. In this role, Grant is part of the team responsible for the management of the Carson Investment platform, In-house Carson model portfolios, and contribution to the overall asset allocation viewpoints of the investment team.Grant received his Bachelor of Science in finance from the University of Nebraska at Lincoln. He is a CFA® Charter holder, holds the Chartered Alternative Investment Analyst (CAIA) designation, DACFP Certificate in Blockchain and Digital Assets, Candriam Certificate in Sustainable and Responsible Investing and Series 65 registration. He is a member of the CFA® Society of Nebraska and the CAIA Chicago chapter. He has contributed to numerous publications and is an active contributor to commentary related to the ETF industry.

Originally Recorded May 25th, 2024 About Professor Carola Binder: https://carolabinder.sites.haverford.edu/wp-content/uploads/2021/07/Carola-Conces-Binder-CV-2021.pdf Check out Professor Binder's book Shock Values: Prices and Inflation in American Democracy: https://www.amazon.com/Shock-Values-Inflation-American-Democracy/dp/0226833097 This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit musicallyspeaking.substack.com

Kafka's Biography written in three parts in German by Reiner Stach is considered as one of the best Biographies published ever. Renowned translator Shelley Frisch rendered it into English with great dexterity and dedication. In this episode, she spoke about her affinity towards the translation of Biographies, Kafka's Allure, Challenges in translating Non-Fiction and how she handled this 3-part 1800-page work. Shelley Frisch taught German literature at Bucknell University, Columbia University, and Haverford College, where she chaired the German Department, before turning to translation full-time in the 1990s. Her translations, which include biographies of Friedrich Nietzsche, Albert Einstein, Leonardo da Vinci, Marlene Dietrich/Leni Riefenstahl (dual biography), and Franz Kafka, have been awarded numerous translation prizes. Among her recent translations are a volume of Billy Wilder's early journalism, an overview of Early German Romanticism, an annotated collection of Kafka's aphorisms, a Holocaust memoir, and a study of the origins of Critical Theory; she is currently translating a biography of Hannah Arendt. She lives in Princeton, New Jersey. * For your Valuable feedback on this Episode - Please click the link below.https://tinyurl.com/4zbdhrwrHarshaneeyam on Spotify App –https://harshaneeyam.captivate.fm/onspotHarshaneeyam on Apple App – https://harshaneeyam.captivate.fm/onapple*Contact us - harshaneeyam@gmail.com ***Disclaimer: The views and opinions expressed by Interviewees in interviews conducted by Harshaneeyam Podcast are those of the Interviewees and do not necessarily reflect the official policy or position of Harshaneeyam Podcast. Any content provided by Interviewees is of their opinion and is not intended to malign any religion, ethnic group, club, organization, company, individual, or anyone or anything.This podcast uses the following third-party services for analysis: Podtrac - https://analytics.podtrac.com/privacy-policy-gdrpChartable - https://chartable.com/privacy

Cyrus Copeland, a writer and nonprofit pioneer, planted his first tree as a tribute to his father—a red oak on the grounds of Valley Forge. Year after year he returned to the tree. But it wasn't until Cyrus traveled to the West Bank and witnessed the deep relationship between Palestinians and their olive trees that an idea sparked: Could planting trees bring prosperity and balance to a high-conflict region? Collaborating with the Palestinian Farmers Union, he launched Treedom for Palestine, harnessing the power of the olive tree as a catalyst for change. Copeland's dedication to civic engagement stems from his parents, educators from Iran and America, who instilled in him the value of fostering understanding among diverse communities. Cyrus began a decade-long career on Madison Avenue developing strategies for clients like Kodak, Chrysler, and Chase, but found his true calling as a writer and social change advocate. His most recent book, OFF THE RADAR (Penguin/Blue Rider), won him the Chautauqua Prize, and his writings have been featured in publications such as The New York Times, The Los Angeles Times, Slate, NPR, and BBC. Beyond his literary achievements, Cyrus is also a sought-after speaker and has delivered talks at conferences and cultural events worldwide. Cyrus is an alum of Haverford College, Villanova, and Cornell University. --- Send in a voice message: https://podcasters.spotify.com/pod/show/plantatrilliontrees/message Support this podcast: https://podcasters.spotify.com/pod/show/plantatrilliontrees/support

Veronika Trufanova always had a passion for environmental sustainability, making her the perfect fit for her role as Director of Development at the Emerald Necklace Conservancy, a historic linear park system in Boston that introduced one the first example of green infrastructure in the nation. Nika now works to sustain the parks impact on the city while growing awareness for its rich history, a huge task in a city with over 650,000 residents.  Nika discusses how Sherry's fresh perspective has revamped her team's strategic plan while generating morale throughout her organization. The two share about the power of curiosity in young fundraisers, and how that energy can translate to your relationships with donors.   What You Will Discover:  ✔️ A well-thought-out, purpose driven strategic plan can unlock the spark your organization needs to take on that big capital campaign ✔️ It's important to take a step back from the everyday grind and celebrate wins, even the smallest victories, to boost morale in your staff and donors ✔️ The most important trait a young fundraiser can have is a curiosity for understanding their organization's mission ✔️ By truly understanding the needs of your organization, you can create a personal and generous atmosphere that allows your donors to really feel like they're making an impact —————————————— Veronika (Nika) directs the Conservancy's fundraising program, including individual, corporate, foundation and government grants, the annual giving program, and other special fundraising initiatives. Nika previously worked at the Asian Art Museum of San Francisco, where she led the Institutional Giving program for over six years, raising unrestricted, project-based and campaign support from corporations, foundations and government granting agencies. She also held several roles on the development team at the Harvard Art Museums, encompassing database management, development operations and donor and member events. Nika holds a bachelor's degree in Art History from Haverford College. She is an avid tea drinker and an unabashed Italophile. LinkedIn: https://www.linkedin.com/in/veronika-trufanova-5770bb8/ Website: https://www.emeraldnecklace.org/ —————————————— Welcome to the Business Behind Fundraising podcast, where you'll discover how to raise the kind of money your big vision requires without adding more events, appeals, or grant applications. Learn how to stop blocking overall revenue growth and start attracting investment-level donors with Sherry Quam Taylor. Sherry Quam Taylor's unique approach and success combine her background of scaling businesses with her decade-long experience advising nonprofit leadership teams. With out-of-the-box principles and a myth-busting methodology, proven results, and an ability to see solutions to revenue problems that others overlook, her clients regularly add 7-figures of revenue to their bottom line. If you need a true partner to show you how to fully finance your entire mission, both programs, AND overhead, year after year… You're in the right place!   #nonprofits #podcast

A sweeping history of the United States' economy and politics, in Shock Values: Prices and Inflation in American Democracy (U Chicago Press, 2024), Carola Binder reveals how the American state has been shaped by a massive, ever-evolving effort to insulate its economy from the real and perceived dangers of price fluctuations. Carola Binder narrates how the pains of rising and falling prices have brought lasting changes for every generation of Americans. And with each brush with price instability, the United States has been reinvented—not as a more perfect union, but as a reflection of its most recent failures. Shock Values tells the untold story of prices and price stabilization in the United States. Expansive and enlightening, Binder recounts the interest-group politics, legal battles, and economic ideas that have shaped a nation from the dawn of the republic to the present. Carola Binder is Associate Professor and Chair of Economics at Haverford College. Twitter. Brian Hamilton is chair of the Department of History and Social Science at Deerfield Academy. Twitter. Website. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

A sweeping history of the United States' economy and politics, in Shock Values: Prices and Inflation in American Democracy (U Chicago Press, 2024), Carola Binder reveals how the American state has been shaped by a massive, ever-evolving effort to insulate its economy from the real and perceived dangers of price fluctuations. Carola Binder narrates how the pains of rising and falling prices have brought lasting changes for every generation of Americans. And with each brush with price instability, the United States has been reinvented—not as a more perfect union, but as a reflection of its most recent failures. Shock Values tells the untold story of prices and price stabilization in the United States. Expansive and enlightening, Binder recounts the interest-group politics, legal battles, and economic ideas that have shaped a nation from the dawn of the republic to the present. Carola Binder is Associate Professor and Chair of Economics at Haverford College. Twitter. Brian Hamilton is chair of the Department of History and Social Science at Deerfield Academy. Twitter. Website. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/political-science

A sweeping history of the United States' economy and politics, in Shock Values: Prices and Inflation in American Democracy (U Chicago Press, 2024), Carola Binder reveals how the American state has been shaped by a massive, ever-evolving effort to insulate its economy from the real and perceived dangers of price fluctuations. Carola Binder narrates how the pains of rising and falling prices have brought lasting changes for every generation of Americans. And with each brush with price instability, the United States has been reinvented—not as a more perfect union, but as a reflection of its most recent failures. Shock Values tells the untold story of prices and price stabilization in the United States. Expansive and enlightening, Binder recounts the interest-group politics, legal battles, and economic ideas that have shaped a nation from the dawn of the republic to the present. Carola Binder is Associate Professor and Chair of Economics at Haverford College. Twitter. Brian Hamilton is chair of the Department of History and Social Science at Deerfield Academy. Twitter. Website. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/american-studies

A sweeping history of the United States' economy and politics, in Shock Values: Prices and Inflation in American Democracy (U Chicago Press, 2024), Carola Binder reveals how the American state has been shaped by a massive, ever-evolving effort to insulate its economy from the real and perceived dangers of price fluctuations. Carola Binder narrates how the pains of rising and falling prices have brought lasting changes for every generation of Americans. And with each brush with price instability, the United States has been reinvented—not as a more perfect union, but as a reflection of its most recent failures. Shock Values tells the untold story of prices and price stabilization in the United States. Expansive and enlightening, Binder recounts the interest-group politics, legal battles, and economic ideas that have shaped a nation from the dawn of the republic to the present. Carola Binder is Associate Professor and Chair of Economics at Haverford College. Twitter. Brian Hamilton is chair of the Department of History and Social Science at Deerfield Academy. Twitter. Website. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/public-policy

Denise talks to Arn Tellem, Vice Chairman of the Detroit Pistons basketball franchise. They discuss many lessons from his distinguished career as one of the top player agents in professional sports. Arn gives tangible advice for both people starting out in their careers as well as seasoned professionals. In particular, he talks about personal lessons of perseverance after losing a player as an agent, and gives suggestions to young people about education and career management. Arn talks about his decision to join the Pistons and how the opportunity to contribute to the region's revitalization was a key factor for him. To that end, he discusses several community partnerships that earned the organization national recognition as he works to strengthen the connection between the Pistons and the community. They discuss the impact of bringing the franchise back to the city of Detroit after a 39-year absence and as well as the organization's growing relationship with Henry Ford Health.    Arn Tellem has represented more than 500 professional athletes in his career. He joined the Detroit Pistons organization as Vice Chairman in 2015, where he has broad responsibility for business and basketball strategy, planning, and development. Over the years, Arn has been recognized as the most influential Sports Agent by the Sports Business Journal, The Sporting News, and Forbes. He has written for numerous national publications, including the New York Times, Sports Illustrated, and the Japan Times, and is frequently invited to lecture on issues related to sports law and business. He received his bachelor's degree from Haverford College and his J.D. degree from the University of Michigan Law School. He is active in the Detroit business and philanthropic community.   Denise Ilitch, an owner of Ilitch Family Companies and President of Ilitch Enterprises, has been a part of Detroit's business and philanthropic community for over 40 years. As a mother, lawyer, entrepreneur, devoted community servant and tireless advocate for women and children, she learned early, from her father, that everyone is worthy of contributing to the world. Her passion for affordable, accessible, quality education stems from her own experience as a first-generation student, earning a bachelor's degree from the University of Michigan, where she currently serves on the Board of Regents, and a law degree from the University of Detroit Law School. FOLLOW DENISE @thedeniseilitchshow

In this episode of Quakers Today, we ask, “What does it mean to be welcomed in a space?” Peterson Toscano (he/him) and Miche McCall (they/them) discuss the concept of feeling welcome. Miche describes their sense of safety under a blanket while podcasting from Logrono, Spain, during their Camino de Santiago pilgrimage. They explore how welcoming spaces can be challenging for individuals with unique identities, especially in religious settings, and emphasize that genuine inclusivity often differs from mere proclamations of welcome. To see our full show notes and transcript visit www.quakerstoday.org Rhiannon Grant  "If the Quaker community were a household, who would be the owners and who would be the guests?" Peterson Toscano chats with Rhiannon Grant (she/her) from Woodbrooke Quaker Learning and Research Centre about her article, “A Family of Friends,” which explores the importance of creating welcoming spaces within Quaker communities. Rhiannon, a lifelong Quaker and member of various faith communities, uses the metaphor of a household to explore the roles and feelings of welcome within Quaker meetings. She also discusses how implicit signals can create exclusion and emphasizes the significance of creating spaces where diverse theological beliefs are openly discussed and valued. Learn more about Rhiannon Grant Rhiannon Grant is Woodbrooke's Deputy Programme Leader for Research and Programme Coordinator for Modern Quaker Thought. Rhiannon's work at Woodbrooke spans academic and practice-based approaches to Quakerism. She teaches in Woodbrooke's short course program, supervises research, and teaches postgraduate students within the Centre for Research in Quaker Studies. Outside Woodbrooke, she researches and writes about Quakers for both academic and general audiences, as well as writing fiction and poetry. Her interests center on British Quakerism in the 20th and 21st centuries, especially Quaker theology, ways of speaking about God, and the developments in practice and religious diversity.  You can follow Rhiannon as @bookgeekrelng on X and on Facebook. Watch a YouTube video of her keynote address about Deep Hospitality. Read her Pendle Hill pamphlet Telling the Truth About God: Quaker Approaches to Theology, and look out for a new one entitled Deep Hospitality.   Lisa Graustein on What is a Welcoming Space? Lisa Graustein (she/her), a diversity, equity, and inclusion (DEI) facilitator, discusses creating truly welcoming spaces in Quaker meetings by ensuring physical accessibility and accommodating diverse needs. She emphasizes the importance of inclusivity, recognizing varied contributions, and continually evaluating if all voices are being heard and needs met. This approach requires ongoing effort and reflection to foster genuine inclusivity. This is a short excerpt from a QuakerSpeak video featuring a variety of voices. The video is entitled What's the Difference Between a Welcoming and an Inclusive Space? See more videos like this on the QuakerSpeak YouTube channel or at QuakerSpeak.org. Learn more about Lisa Graustein. Lisa Graustein is a teacher, facilitator, and artist who holds an MEd in racial justice education. For 20 years, she taught in public middle and high schools. Currently, Lisa works as a DEI facilitator and trainer with schools and nonprofits throughout the northeast. She has been a facilitator for Beyond Diversity 101. A Univeralist Friend, she is part of a group of Quakers founding Three Rivers Meeting, a Queer, Christian Quaker meeting. A solo mom and potter, Lisa lives in an intentional community on the unceded Neponset Band of the Massachusetts land. Reviews More than a Dream: The Radical March on Washington for Jobs and Freedom by Yohuru Williams and Michael G. Long provides an in-depth look at the 1963 March on Washington, highlighting the crucial roles of activists like Bayard Rustin. This makes it ideal for middle school students. The book has been longlisted for the 2023 National Book Awards in the category of Young People's Literature. The First Day of Peace by Todd Schuster and Maya Soetoro-Ng, illustrated by Tatiana Gardel, tells the story of two communities coming together to help each other, illustrating the concept of peace and welcome for children. More than a Dream: The Radical March on Washington for Jobs and Freedom reviewed by Gwen Gosney Erickson The First Day of Peace reviewed by Katie Green See all of the May 2024 Reviews on Friends Journal Closing  Peterson and McCall discuss their upcoming participation in the 2024 Friends General Conference at Haverford College, where Miche will lead earth-centered worship with Quaker Earth Witness and Peterson will conduct interviews for the podcast.  You can now follow Quakers Today on Instagram, TikTok, and the platform now known as X.  Question for next month Who is a historical figure whom you admire but whose actions and words also trouble you? Historians, activists, and content creators help us gain a fuller, more balanced view of often revered historical figures. We learn that the heroes of old were not perfect.  Leave a text or voice memo with your name and the town where you live. The number to call is 317-QUAKERS, that's 317-782-5377. +1 if calling from outside the U.S. You can also comment on our social media or email us podcast@friendsjournal.org.  Quakers Today is the companion podcast to Friends Journal and other Friends Publishing Corporation (FPC) content online. It is written, hosted, and produced by Peterson Toscano and Miche McCall with assistance from Christopher Cuthrell. Season Three of Quakers Today is sponsored by American Friends Service Committee.  Do you want to challenge unjust systems and promote lasting peace? The American Friends Service Committee, or AFSC, works with communities worldwide to drive social change. Their website features meaningful steps you can take to make a difference. Through their Friends Liaison Program, you can connect your meeting or church with AFSC and their justice campaigns. Find out how you can become part of AFSC's global community of changemakers. Visit AFSC.org.  Feel free to send comments, questions, and requests. Email us at podcast@friendsjournal.org. Call our listener voicemail line: 317-QUAKERS.Music from this episode comes from Epidemic Sound.

On this edition of The Catered Quiz, Rick welcomes Kent Watson to the show and thanks him for helping inspire The Catered Quiz. Kent shares what he's been up to at Haverford College and also talks about his new album Put Your Arm Thing On My Shoulder by Sludge Monster, available now on Spotify & Bandcamp. Kent then answers questions about Frasier and Monster Movies. Listen to Put Your Arm Thing On My Shoulder on either Bandcamp or Spotify. And check out a wide variety of Kent's projects at https://kwworking.com/

Synopsis: In this episode of Biotech2050, Dr. Ted Love, former CEO of Global Blood Therapeutics and Current Chairman of BIO, shares insights on sickle cell breakthroughs, transitioning from academia to research, navigating a tight funding environment, and protecting an innovative ecosystem to benefit patients. Biography: Dr. Ted Love is the chair of the Board of Directors at the Biotechnology Innovation Organization (BIO), a position he assumed in June 2023. A long-time BIO Board Member, Dr. Love has focused on championing access to care, standing up for science, and improving the narrative around the biopharma industry. Dr. Love previously served as president and chief executive officer of Global Blood Therapeutics (GBT). During his tenure at GBT, Dr. Love led the company from a pre-clinical start-up, through the accelerated approval and launch of Oxbryta®, and into a global commercial company with an advanced pipeline of innovative therapies focused on sickle cell disease. Prior to GBT, Dr. Love was executive vice president, research and development and technical operations, at Onyx Pharmaceuticals, Inc., where he played an instrumental role in the accelerated approval of Kyprolis® for multiple myeloma, and the subsequent purchase of Onyx by Amgen. Previously, Dr. Love served as president, chief executive officer and chairman of Nuvelo, Inc., and as senior vice president, development, at Theravance, Inc. Dr. Love began his biotech career at Genentech in 1992, where he held several senior management positions in clinical science and product development, and ultimately as chairman of Genentech's Product Development Committee. As vice president, product development, Dr. Love oversaw the development strategy and execution leading to approvals of Rituxan®, Herceptin®, Xolair®, TNKase®, Raptiva® and Avastin®. Prior to Genentech, Dr. Love was a member of the Department of Cardiology at the Massachusetts General Hospital. Dr. Love currently serves on the boards of directors of Royalty Pharma and Structure Therapeutics. Dr. Love holds a B.A. in molecular biology from Haverford College and an M.D. from Yale Medical School. He completed a residency in internal medicine and a fellowship in cardiology at the Massachusetts General Hospital.

Subscribe to Receive Venkat's Weekly Newsletter Christina was involved in a lot of activities in High School. She was at Science Fairs. She was on the Tennis team, quiz bowl. She did choir, theater, acapella, and leadership roles. But Science was her main thing. Christina joins our podcast to share her undergraduate experience at Haverford College, Interest in Research, Winning the Goldwater Scholarship, and Advice for High Schoolers. In particular, we discuss the following with her:  Overall Haverford Experience Natural Product Biosynthesis Research The Goldwater Scholarship Advice to High Schoolers Topics discussed in this episode: Introduction to Christina McBride, Haverford College [] Hi Fives - Podcast Highlights [] Overall Haverford Experience [] Why Haverford? [] High School Interests [] Research in High School [] Transition to College [] Peers & Profs [] Starting UG Research [] The Research [] Research Outcomes [] Applying for Goldwater Scholarship [] Winning The Goldwater Scholarship [] The GW Difference [] Research Impact [] Majoring in Chemistry [] Campus Activities [] Advice for High Schoolers [] Memory [] Our Guest: Christina McBride is a Goldwater Scholar who graduated with a Bachelor's degree in Chemistry from Haverford College in Pennsylvania. Christina is currently pursuing her PhD in Chemical Biology at the University of Michigan Ann Arbor. Memorable Quote: “I can say my main thing is to really explore and to kind of take that jump, even if you feel unprepared, or that you don't necessarily have the skills that other people do, because you want to be able to explore so many different areas. Because even if something is tough, that doesn't mean that it's impossible. ” Christina McBride. Episode Transcript: Please visit Episode's Transcript. Similar Episodes: College Experiences , UG Research Calls-to-action: Follow us on Instagram. To Ask the Guest a question, or to comment on this episode, email podcast@almamatters.io. Subscribe or Follow our podcasts at any of these locations: Apple Podcasts, Spotify.

Subscribe to our channel: https://www.youtube.com/@optispan We talk a lot about the science of longevity and healthspan on the Optispan podcast—how DEXA scans work, what an optimal rapamycin dose might look like, how the intersection of optogenetics and mitochondria are helping us understand biological aging, what supplements one might consider taking and why. But the longevity field runs on way more than just science. It takes a village—a community of researchers, engineers, entrepreneurs, investors, regulators, and beyond who believe in the value of tackling the biology of aging as a crucial strategy for extending healthy lifespan—to create tangible results that benefit as many people as possible. At Optispan, we're eager to support and interact with the many levers that keep this machine going. One of these is the Alliance for Longevity Initiatives (A4LI), a nonprofit organization focused on catalyzing social and political action that will benefit the longevity field. In this episode, Matt chats with A4LI founder, president, and CEO Dylan Livingston about forming a bipartisan longevity science caucus, redirecting funding towards geroscience research, and engaging with policymakers to help them understand the importance of transitioning towards a proactive healthcare model. Dylan, who founded A4LI in 2021, served as a field organizer for President Joe Biden's 2020 presidential campaign. He also worked as a community organizer for Organizing Corps 2020, where he registered hundreds of Democratic voters in Pennsylvania for the 2020 presidential compaign. Dylan graduated from Haverford College with a B.S. in physics and a minor in economics. Matt joined the A4LI Board of Directors in 2024. Producers: Tara Mei, Nicholas Arapis Video Editor: Jacob Keliikoa DISCLAIMER: The information provided on the Optispan YouTube channel is intended solely for general educational purposes and is not meant to be, nor should it be construed as, personalized medical advice. No doctor-patient relationship is established by your use of this channel. The information and materials presented are for informational purposes only and are not a substitute for professional medical advice, diagnosis, or treatment. We strongly advise that you consult with a licensed healthcare professional for all matters concerning your health, especially before undertaking any changes based on content provided by this channel. The hosts and guests on this channel are not liable for any direct, indirect, or other damages or adverse effects that may arise from the application of the information discussed. Medical knowledge is constantly evolving; therefore, the information provided should be verified against current medical standards and practices. More places to find us: Twitter: https://twitter.com/optispanpodcast Twitter: https://twitter.com/optispan Twitter: https://twitter.com/mkaeberlein Linkedin: https://www.linkedin.com/company/optispan https://www.optispan.life/ Hi, I'm Matt Kaeberlein. I spent the first few decades of my career doing scientific research into the biology of aging, trying to understand the finer details of how humans age in order to facilitate translational interventions that promote healthspan and improve quality of life. Now I want to take some of that knowledge out of the lab and into the hands of people who can really use it. On this channel I talk about all things aging and healthspan, from supplements and nutrition to the latest discoveries in longevity research. My goal is to lift the veil on the geroscience and longevity world and help you apply what we know to your own personal health trajectory. I care about quality science and will always be honest about what I don't know. I hope you'll find these videos helpful!

In this episode you will hear:   (01:50) Mark and Vince will eventually discuss an article on how students are being coached to brand themselves in their applications. This is an article that appeared in the NY Times by a Guest Essayist, entitled, “Elite college admissions have turned students into brands” but they get into that article in Part 2, on Episode 421, that will air on April 11th, but this week, Vince and Mark discuss their observations from this year in college admissions; they also share some admission tips, an admission vernacular and a big number; the big number really inspired Mark     (49:50) Question from a listener Jennifer from Texas wants to know what they should do when they learn about some serious racial incidents that occurred at a college her student was considering applying to (01:05:40) Interview Lydia Dagenais, a former admission officer at Haverford College and Swarthmore College is joined by Julia Esquivel, a co-host for YCBK but also a former Haverford College admission officer to discuss how Law School admissions works-Part 2 of 2 Preview of Part 2 of 2 ²  Lydia lets us know if students can get access to LSAC ²  What role does writing ability and critical thinking play in the admission process? ²  Lydia talks about the content of the first year in law school ²  Lydia talks about whether you need to go to a top tier law school to get the plum jobs after graduation ²  Lydia answers the question, are there too many lawyers out there, is the field oversaturated? ²  Lydia tells us what the character and fitness questions are and she tells us why they are so important ²  Lydia goes on the hot seat     (01:36:08) College Spotlight Kevin Newton joins us to talk about the University of Edinburgh in Scotland, Part 2 of 2   (01:26:35) Recommended Resource: A new podcast about going to college in another country, An Education Abroad is the new podcast by Kevin Newton, founder of , An Education Abroad. Kevin is a frequent guest on YCBK, including in today's episode when he helps us to understand, the University of Edinboro         Speakpipe.com/YCBK is our method if you want to ask a question and we will be prioritizing all questions sent in via Speakpipe.   You can also use this for many other purposes: 1) Send us constructive criticism about how we can improve our podcast 2) Share an encouraging word about something you like about an episode or the podcast in general 3) Share a topic or an article you would like us to address 4) Share a speaker you want us to interview 5) Leave positive feedback for one of our interviewees. We will send your verbal feedback directly to them and I can almost assure you, your positive feedback will make their day. If you have a question for one of our upcoming interviews with admissions professionals, here is a list of admissions professionals who we will interview in 2023 or 2024.   To sign up to receive Your College-Bound Kid PLUS, our new monthly admissions newsletter, delivered directly to your email once a month, just go to yourcollegeboundkid.com, and you will see the sign-up popup.   Check out our new blog. We write timely and insightful articles on college admissions:   Follow Mark Stucker on Twitter to get breaking college admission news, and updates about the podcast before they go live. You can ask questions on Twitter that he will answer on the podcast. Mark will also share additional hot topics in the news and breaking news on this Twitter feed. Twitter message is also the preferred way to ask questions for our podcast:   https://twitter.com/YCBKpodcast   1. To access our transcripts, click: https://yourcollegeboundkid.com/category/transcripts/ 2. Find the specific episode transcripts for the one you want to search and click the link 3. Find the magnifying glass icon in blue (search feature) and click it 4. Enter whatever word you want to search. I.e. Loans 5. Every word in that episode when the words loans are used, will be highlighted in yellow with a timestamps 6. Click the word highlighted in yellow and the player will play the episode from that starting point 7. You can also download the entire podcast as a transcript   We would be honored if you will pass this podcast episode on to others who you feel will benefit from the content in YCBK.   Please subscribe to our podcast. It really helps us move up in Apple's search feature so others can find our podcast.   If you enjoy our podcast, would you please do us a favor and share our podcast both verbally and on social media? We would be most grateful!   If you want to help more people find Your College-Bound Kid, please make sure you follow our podcast. You will also get instant notifications as soon as each episode goes live.   Check out the college admissions books Mark recommends:   Check out the college websites Mark recommends:   If you want to have some input about what you like and what you recommend, we change about our podcast, please complete our Podcast survey; here is the link:     If you want a college consultation with Mark or Lisa or Lynda, just text Mark at 404-664-4340 or email Lisa at or Lynda at Lynda@schoolmatch4u.com. All we ask is that you review their services and pricing on their website before the complimentary session; here is link to their services with transparent pricing: https://schoolmatch4u.com/services/compare-packages/

In this episode you will hear:   (06:30) Julia and Mark discuss an article by “Dean of Admissions Claudia Marroquin on the decline of male applicants to Bowdoin” but Julia and Mark know this is a national crisis, so they discuss the article in the context of the national challenge. Part 3 of 3     Mark shares a moving email that came in this week about why college is turning off many families.   (45:10) Question from a listener Clare from VA asks about a special program offered at her school. She wants to know how colleges read transcripts from students who take these special programs (01:05:50) Interview Lydia Dagenais, a former admission officer at Haverford College and Swarthmore College is joined by Julia Esquivel, a co-host for YCBK but also a former Haverford College admission officer to discuss how Law School admissions works Preview of Part 1 of 2 ²  How does Law school admissions work? ²  Lydia tells us what LSAC is and she talks about the central role of LSAC in law school admissions ²  Lydia talks about the requirements for the law school application ²  Lydia talks about the role of the American Bar association ²  Lydia talks about how the role of testing differs for law schools vs undergrad ²  Lydia tells us what JD Next is ²  Lydia shares what a student can do now to prepare for law school? ²  Lydia gives some great advice on who to ask for your recommendations for law school? ²  I ask Lydia to go in more depth about how LSAC helps the law school file reading process. ²  Lydia talks about the role predictive modeling plays in law schools admissions       (01:38:47) College Spotlight Kevin Newton joins us to talk about the University of Edinburgh in Scotland, Part 1 of 2   (01:22:48) Recommended Resource:  Episode Dr. Lisa Damour interview         Speakpipe.com/YCBK is our method if you want to ask a question and we will be prioritizing all questions sent in via Speakpipe.   You can also use this for many other purposes: 1) Send us constructive criticism about how we can improve our podcast 2) Share an encouraging word about something you like about an episode or the podcast in general 3) Share a topic or an article you would like us to address 4) Share a speaker you want us to interview 5) Leave positive feedback for one of our interviewees. We will send your verbal feedback directly to them and I can almost assure you, your positive feedback will make their day. If you have a question for one of our upcoming interviews with admissions professionals, here is a list of admissions professionals who we will interview in 2023 or 2024.   To sign up to receive Your College-Bound Kid PLUS, our new monthly admissions newsletter, delivered directly to your email once a month, just go to yourcollegeboundkid.com, and you will see the sign-up popup.   Check out our new blog. We write timely and insightful articles on college admissions:   Follow Mark Stucker on Twitter to get breaking college admission news, and updates about the podcast before they go live. You can ask questions on Twitter that he will answer on the podcast. Mark will also share additional hot topics in the news and breaking news on this Twitter feed. Twitter message is also the preferred way to ask questions for our podcast:   https://twitter.com/YCBKpodcast   1. To access our transcripts, click: https://yourcollegeboundkid.com/category/transcripts/ 2. Find the specific episode transcripts for the one you want to search and click the link 3. Find the magnifying glass icon in blue (search feature) and click it 4. Enter whatever word you want to search. I.e. Loans 5. Every word in that episode when the words loans are used, will be highlighted in yellow with a timestamps 6. Click the word highlighted in yellow and the player will play the episode from that starting point 7. You can also download the entire podcast as a transcript   We would be honored if you will pass this podcast episode on to others who you feel will benefit from the content in YCBK.   Please subscribe to our podcast. It really helps us move up in Apple's search feature so others can find our podcast.   If you enjoy our podcast, would you please do us a favor and share our podcast both verbally and on social media? We would be most grateful!   If you want to help more people find Your College-Bound Kid, please make sure you follow our podcast. You will also get instant notifications as soon as each episode goes live.   Check out the college admissions books Mark recommends:   Check out the college websites Mark recommends:   If you want to have some input about what you like and what you recommend, we change about our podcast, please complete our Podcast survey; here is the link:     If you want a college consultation with Mark or Lisa or Lynda, just text Mark at 404-664-4340 or email Lisa at or Lynda at Lynda@schoolmatch4u.com. All we ask is that you review their services and pricing on their website before the complimentary session; here is link to their services with transparent pricing: https://schoolmatch4u.com/services/compare-packages/

Full Hour | In today's second hour, Dom continues the Dom Giordano Program by offering up some concerning information about Haverford College, who this past month have hosted an Israel Apartheid Month, telling that the College is now putting out a blood libel telling that Israel has used Coronavirus ‘as a tool for settler Colonialism in Palestine.' Then, Dom welcomes in Delaware County District Attorney Jack Stollsteimer back onto the Dom Giordano Program to discuss his run for Attorney General of Pennsylvania. Stollsteimer speaks on many of his platform issues, with Dom digging in on certain topics he disagrees with the candidate on, including his stance on the death penalty. After the break, Dom hears from FOP Lodge 27 President Chris Eiserman, who calls in to throw his full support behind Jack in his run to become Attorney General. (Photo by Getty Images)

In this episode you will hear:   (02:15) Julia and Mark planned to  talk about an article that ran in Bowdoin Orient, their student newspaper entitled: “Dean of Admissions Claudia Marroquin on the decline of male applicants to Bowdoin” but they don't get to the article until next week but they do discuss some application tips. Part 2 of 3   (25:55) Question from a listener Do you have any tips for my son who was admitted ED but now he is seeing all of his classmates get in schools in EA and RD and he is questioning his decision to apply ED. (38:32) Interview Lydia Dagenais, a former admission officer at Haverford College and Swarthmore College is joined by Julia Esquivel, a co-host for YCBK but also a former Haverford College admission officer to discuss Haverford and Swarthmore Preview ²  Julia, so what do you want our listeners to know about Lydia that she didn't share? ²  Julia, explain the bi-co and tri-co consortium in case our listeners are not familiar with it         (01:05:12) Mark and Lisa talk about Marquette University in our College Spotlight section, Part 2 of 2   (52:52) Recommended Resource:      and here are the dates for ScholarMatch information sessions:  (PST) 5 MST 6 CST 7 EST  (PST) 11 MST, 12 CST 1 PM EST   Here is a link to the ScholarMatch volunteer form:     Speakpipe.com/YCBK is our method if you want to ask a question and we will be prioritizing all questions sent in via Speakpipe.   You can also use this for many other purposes: 1) Send us constructive criticism about how we can improve our podcast 2) Share an encouraging word about something you like about an episode or the podcast in general 3) Share a topic or an article you would like us to address 4) Share a speaker you want us to interview 5) Leave positive feedback for one of our interviewees. We will send your verbal feedback directly to them and I can almost assure you, your positive feedback will make their day. If you have a question for one of our upcoming interviews with admissions professionals, here is a list of admissions professionals who we will interview in 2023 or 2024.   To sign up to receive Your College-Bound Kid PLUS, our new monthly admissions newsletter, delivered directly to your email once a month, just go to yourcollegeboundkid.com, and you will see the sign-up popup.   Check out our new blog. We write timely and insightful articles on college admissions:   Follow Mark Stucker on Twitter to get breaking college admission news, and updates about the podcast before they go live. You can ask questions on Twitter that he will answer on the podcast. Mark will also share additional hot topics in the news and breaking news on this Twitter feed. Twitter message is also the preferred way to ask questions for our podcast:   https://twitter.com/YCBKpodcast   1. To access our transcripts, click: https://yourcollegeboundkid.com/category/transcripts/ 2. Find the specific episode transcripts for the one you want to search and click the link 3. Find the magnifying glass icon in blue (search feature) and click it 4. Enter whatever word you want to search. I.e. Loans 5. Every word in that episode when the words loans are used, will be highlighted in yellow with a timestamps 6. Click the word highlighted in yellow and the player will play the episode from that starting point 7. You can also download the entire podcast as a transcript   We would be honored if you will pass this podcast episode on to others who you feel will benefit from the content in YCBK.   Please subscribe to our podcast. It really helps us move up in Apple's search feature so others can find our podcast.   If you enjoy our podcast, would you please do us a favor and share our podcast both verbally and on social media? We would be most grateful!   If you want to help more people find Your College-Bound Kid, please make sure you follow our podcast. You will also get instant notifications as soon as each episode goes live.   Check out the college admissions books Mark recommends:   Check out the college websites Mark recommends:   If you want to have some input about what you like and what you recommend, we change about our podcast, please complete our Podcast survey; here is the link:     If you want a college consultation with Mark or Lisa or Lynda, just text Mark at 404-664-4340 or email Lisa at or Lynda at Lynda@schoolmatch4u.com. All we ask is that you review their services and pricing on their website before the complimentary session; here is link to their services with transparent pricing: https://schoolmatch4u.com/services/compare-packages/

In this episode you will hear:   (02:10) Julia and Mark planned to  talk about an article that ran in Bowdoin Orient, their student newspaper entitled: “Dean of Admissions Claudia Marroquin on the decline of male applicants to Bowdoin” but they don't get to the article until next week but they do discuss some application tips including, should you write your Personal Statement on Your College Major? Part 1 of 2     (24:36) Question from a listener Marissa Salazar, Associate Director of Admissions at Colorado College answers a couple questions about applications from the state of Florida in our QFL section   (35:55) Interview Lydia Dagenais, a former admission officer at Haverford College and Swarthmore College is joined by Julia Esquivel, a co-host for YCBK but also a former Haverford College admission officer to discuss Haverford and Swarthmore Preview ²  Lydia shares her backstory ²  I ask Lydia, the students that pick Swarthmore over Haverford, why do they do it, and the students that pick Haverford over Swarthmore, why do they do it? ²  Julia, so what do you want our listeners to know about Lydia that she didn't share? ²  Julia, explain the bi-co and tri-co consortium in case our listeners are not familiar with it     (41:10) Recommended Resource: Getting In    (01:00:35) Mark and Lisa talk about Marquette University in our College Spotlight section, Part 1 of 2      Recommended Resource- T  Do it yourself college rankings and and here are the dates for ScholarMatch information sessions:  (PST) 5 MST 6 CST 7 EST  (PST) 11 MST, 12 CST 1 PM EST   Here is a link to the ScholarMatch volunteer form:     Speakpipe.com/YCBK is our method if you want to ask a question and we will be prioritizing all questions sent in via Speakpipe.   You can also use this for many other purposes: 1) Send us constructive criticism about how we can improve our podcast 2) Share an encouraging word about something you like about an episode or the podcast in general 3) Share a topic or an article you would like us to address 4) Share a speaker you want us to interview 5) Leave positive feedback for one of our interviewees. We will send your verbal feedback directly to them and I can almost assure you, your positive feedback will make their day. If you have a question for one of our upcoming interviews with admissions professionals, here is a list of admissions professionals who we will interview in 2023 or 2024.   To sign up to receive Your College-Bound Kid PLUS, our new monthly admissions newsletter, delivered directly to your email once a month, just go to yourcollegeboundkid.com, and you will see the sign-up popup.   Check out our new blog. We write timely and insightful articles on college admissions:   Follow Mark Stucker on Twitter to get breaking college admission news, and updates about the podcast before they go live. You can ask questions on Twitter that he will answer on the podcast. Mark will also share additional hot topics in the news and breaking news on this Twitter feed. Twitter message is also the preferred way to ask questions for our podcast:   https://twitter.com/YCBKpodcast   1. To access our transcripts, click: https://yourcollegeboundkid.com/category/transcripts/ 2. Find the specific episode transcripts for the one you want to search and click the link 3. Find the magnifying glass icon in blue (search feature) and click it 4. Enter whatever word you want to search. I.e. Loans 5. Every word in that episode when the words loans are used, will be highlighted in yellow with a timestamps 6. Click the word highlighted in yellow and the player will play the episode from that starting point 7. You can also download the entire podcast as a transcript   We would be honored if you will pass this podcast episode on to others who you feel will benefit from the content in YCBK.   Please subscribe to our podcast. It really helps us move up in Apple's search feature so others can find our podcast.   If you enjoy our podcast, would you please do us a favor and share our podcast both verbally and on social media? We would be most grateful!   If you want to help more people find Your College-Bound Kid, please make sure you follow our podcast. You will also get instant notifications as soon as each episode goes live.   Check out the college admissions books Mark recommends:   Check out the college websites Mark recommends:   If you want to have some input about what you like and what you recommend, we change about our podcast, please complete our Podcast survey; here is the link:     If you want a college consultation with Mark or Lisa or Lynda, just text Mark at 404-664-4340 or email Lisa at or Lynda at Lynda@schoolmatch4u.com. All we ask is that you review their services and pricing on their website before the complimentary session; here is link to their services with transparent pricing: https://schoolmatch4u.com/services/compare-packages/

Cricket was once the most popular summer game in the United States – the first ever international match was played not, as you might expect between England and one of its colonies, but between Canada and the United States, in 1844. The first overseas England tour was to the US in 1859. The professional players earned the unheard-of sum of 90 pounds – America then, just as now, was an El Dorado of sporting riches. Yet just ten years later, after four years of civil war and the rebirth of a newly consolidated United States, the new sport of baseball had all but erased cricket from the New York sporting press. The prize money and betting markets that were once drawn to the cricket field now turned to the baseball diamond. As one old American cricketer sadly observed in his memoirs, “We had a large number of good young men playing the game up to the time when the war fever took hold of them. When hostility between North and South broke out, away went our players to the front and the cricket field was deserted. Those that returned from the war never took up the game again.” So, what went wrong? How can we explain the strange death of American cricket, and how should we explain its present-day partial revival? Adam talks to Ed Smith, former England cricketer and an award-winning journalist and to Joe Lynn Curator at The C. Christopher Morris Cricket Library at Haverford College. Hosted on Acast. See acast.com/privacy for more information.

Everywhere we look its about us. How "we" want things, "our" true self, "our" vision of the world, what "we" want, etc. Even algorithms cater to us, giving us more and more of what we want, but is that the secret to happiness? Getting more of what "we" want? There is a better way. By taking the focus off of ourselves and getting our focus back on God, that's not easy. We need some help. Who could help us refocus? How about from "those who are dead and yet still speak"? We need to go back and listen to those voices with God-centered lives: Jonathan Edwards, C.S. Lewis, and Augustine. Today, we welcome one of the greatest living historians of American history, George Marsden, who can help us do just that. Dr. Marsden brings Edwards into the twenty-first century, along with Augustine and C.S. Lewis, he helps us to see how we can reorient our lives in our modern times to be more God-centered and ordered by our loves rather than the algorithms of our modern world. Dr. Marsden is Professor of History Emeritus at the University of Notre Dame, is an influential historian who has written extensively on the interaction between Christianity and American culture, particularly on Christianity in American higher education and on American evangelicalism. He is well known for his biography Jonathan Edwards: A Life. He has authored other books including The Soul of the American University, Religion and American Culture, Fundamentalism and American Culture, and C.S. Lewis's “Mere Christianity”: A Biography. Marsden studied at Haverford College, Westminster Theological Seminary, and Yale University; he has taught at Calvin University, Duke University, and the University of Notre Dame. Today, we discuss his newest book on Edwards, "An Infinite Fountain of Light: Jonathan Edwards for the Twenty-First Century."Sign up for the Apollos Watered newsletter.Help water-thirsty souls by partnering with Apollos Watered!

Zoe Chance, Yale lecturer and author of the international bestseller, INFLUENCE IS YOUR SUPERPOWER, studies persuasion, decision making, and how people can lead happier, healthier, more fulfilling lives. At Yale, Zoe teaches one of Yale's most popular classes, Mastering Influence and Persuasion. She also collaborates with Google and Optum Health. Prior to her engagement at Yale, Zoe marketed a $200 million segment of the Barbie brand at Mattel and developed an executive education leadership program at Harvard. Her research has been covered in the New York Times, the Wall Street Journal, the Economist, Scientific American, Psychology Today, Financial Times, and Discover. Zoe received her doctorate from Harvard, MBA from the University of Southern California, and bachelor's degree from Haverford College. In this episode we discuss the following: Those who had advantages were seven times more likely to ask for help than those who didn't. But, if we help those who ask and don't seek out and support those who don't ask for help, we further perpetuate inequality. By developing policies with an eye towards helping those who are less likely to ask for help, we can help level the playing field. A lot of privilege in this world is a result of asking for help. But when we help those who ask for help, we can unintentionally perpetuate the Asking Gap, as we help those who already have more privilege. An employee who had just had a child was struggling to keep up with work. So, she asked to work remotely. The manager, being kind, agreed. But the two previous mothers who had just given birth, but hadn't asked to work remotely, were short changed. So, the company created a policy allowing all mothers the same benefit. To reduce the Asking Gap, Zoe automatically grants a two-day extension to anyone who asks. All they have to do is send an email to an email address which automatically responds with the extension. Follow Zoe X: https://twitter.com/zoebchance LinkedIn: https://www.linkedin.com/in/zoebchance/ Website: https://www.zoechance.com/ Book: INFLUENCE IS YOUR SUPERPOWER, Follow Me: X: https://twitter.com/nate_meikle LinkedIn: https://www.linkedin.com/in/natemeikle/ Instagram: https://www.instagram.com/nate_meikle/ Website: https://natemeikle.com

What happened after the Big Bang? To answer this question, I invited a true pioneer in the field of cosmic microwave background, Bruce Partridge! Bruce Partridge is an emeritus professor of astronomy in the science department at Haverford College. He has served as an Education Officer of the American Astronomical Society, president of the Commission on Cosmology, International Astronomical Union, and President of the Astronomical Society of the Pacific.  His research interests lie in the intersection of cosmology and radio astronomy, and he spent most of his career researching the cosmic microwave background. Join us as we embark on a captivating journey into the early Universe! Key Takeaways:  Intro (00:00) Judging a book by its cover (01:27) Coupling together theory and experiment (04:18) The discovery of the coming microwave background (07:23) Patience and perseverance in scientific research (15:01) Nerve gas and rabbits in Arizona (18:27) Why we need to listen to theorists (21:05)  Inflation and the dominance of a theoretical paradigm (24:59)  The Big Bang, CMB, and the lithium abundance problem (33:33) Bruce's philosophy of pedagogy (47:40) Outro (52:48) — Additional resources: 

Today's Headlines: A hostage deal, delayed by cross-allegations, successfully unfolded over the weekend. Hamas released 58 hostages, including a 4-year-old American, while Israel released over 100 Palestinians. The truce is set to end today, but extensions could see the daily release of 10 hostages. In the West Bank, two Palestinians accused of collaboration were killed by the Tulkarm Brigades, warning others to come forward by December 5th to avoid a similar fate. The Israeli military remains committed to operations until Hamas is eradicated. In Burlington, Vermont, a potentially hate-motivated shooting occurred, targeting three Palestinian college students who were shot multiple times by an unidentified white male while walking downtown wearing kaffiyehs. The victims, students from Brown University, Haverford College, and Trinity College, had gathered in Burlington to celebrate Thanksgiving and remain in serious condition. The shooter fled the scene, and police are actively investigating. In other news, Congress is gearing up for a vote on the potential expulsion of Representative George Santos, following a scathing House Ethics Committee report revealing his misuse of campaign funds for personal expenses. Additionally, major egg producers were found guilty of conspiring to limit the U.S. egg supply between 2004 and 2008, raising prices, while a far-right party led by Geert Wilders secured a surprising victory in Dutch parliamentary elections. On a lighter note, U.S. consumers set a new online spending record for Black Friday, reaching $9.8 billion, marking a 7.5% increase from the previous year. Resources/Articles mentioned in this episode: WA Post: Hamas releases American girl with 16 others, Biden says Reuters: Palestinian militants in West Bank say two 'collaborators' executed  WA Post: Three Palestinian American students injured after Vermont shooting The Guardian: ‘It doesn't look good': George Santos expects to be expelled from Congress  AP News: U.S. egg producers conspired to fix prices from 2004 to 2008, a federal jury ruled BBC News: Geert Wilders' victory in Netherlands election spooks Europe  Axios: Americans set record online Black Friday spend Morning Announcements is produced by Sami Sage alongside Amanda Duberman and Bridget Schwartz Edited by Grace Hernandez-Johnson Learn more about your ad choices. Visit megaphone.fm/adchoices

Today's guest, Dr. Andrew Hartz, is a psychologist who has noticed how politicized the world of therapy has become. Over the last few years, he has noticed a climate of patients not being able to talk about what's on their mind without getting a lecture from their therapist about racial injustice, as well as an environment that teaches clinicians to look at patients through a politicized lens. Guest Bio Dr. Andrew Hartz's is a clinical psychologist who holds the position of a professor of clinical psychology at Long Island University in Brooklyn. Hartz received training at Columbia Medical Center, Mount Sinai Hospital, and the William Alanson White Institute, and has completed coursework at Columbia University, Columbia Medical Center, Haverford College, and Long Island University. He uses evidence-based tools from CBT, DBT, and psychodynamic psychotherapies to address the unique needs of each patient. He is also the founder of The Open Therapy Institute which offers mental health resources for overlooked patient populations in a heated political atmosphere. Want early access to episodes and bonus conversations? Upgrade your subscription here. HOUSEKEEPING ☕️ Follow me on Substack.

This week we're talking about the proposed cuts and layoffs at West Virginia University, and to do it we've enlisted a damn platoon. First we have Dennis Hogan, a postdoctoral fellow at Haverford College, who has an article in The Baffler this week about the WVU situation (link below). Then we have two grad students at WVU, Bethany Winters and Christian Rowe, who are involved in the union (@westvirginiaunited on Instagram, @wvunitedsu on Twitter). Finally we have writer and professor Glenn Taylor (@GlennTaylorBook on Twitter), who teaches in WVU's creative writing department. Check out Dennis Hogan's article here: https://thebaffler.com/latest/capture-the-flagship-hogan To contact the board of governors valerie.lopez@mail.wvu.edu To contact the provost provost@mail.wvu.edu To contact the vice president of strategic initiatives rob.alsop@mail.wvu.edu Petition for vote of no-confidence in Gee: https://www.change.org/p/support-wvu-assembly-resolution-of-no-confidence-in-gordon-gee Petition to save creative writing program: https://www.change.org/p/save-wvu-s-mfa-program-preserve-the-future-of-creative-writing-education?utm_medium=custom_url&utm_source=share_petition&recruited_by_id=90780690-c462-012f-672a-4040acce234c